hg_12575.1

Basic information about the TSS

---

TSS ID: hg_12575.1 Species: human Chr: chr1		Start: 58783973 End: 58783984 Strand: -
TSS cluster detected*

  * The number of TSS cluster called studies (maximum 16)

Gene and protein annotation

---

Transcript_name: BC002646 Distance: -32 GeneID: 3725 HGNC/MGI_ID: HGNC:6204 UniProt_ID:

Gene_name: jun proto-oncogene Gene_symbol: JUN Gene_synonyms: AP-1 c-Jun Gene_source: HGNC:6204

TATA-Box annotation

---

Distance to TSS:	134
Nearest PromoterID:	NM_002228
Entrez ID:	3725
Nearest Unigene:	Hs.696684
Nearest Refseq:	NM_002228
Nearest Ensembl:	ENSG00000177606
Gene Name:	jun proto-oncogene
Gene Alias:	AP-1
Gene Description:	"Jun proto-oncogene, AP-1 transcription factor subunit"
Gene Type:	protein-coding
CpG%:	0.04
GC%:	0.562189
TATA-Box(TBP)/Promoter/Homer Distance From TSS(sequence,strand,conservation):

TSS expression

Sample Category  All in vivo cell sample cell line sample tissue sample human bronchial epithelial cell sample CD19-positive B cell sample CD8-positive T cell sample CD4-positive T cell sample common myeloid progenitor sample human monocyte immature derived dendritic cell sample human endothelial cell of the aorta sample human cardiac fibroblast sample human dermal fibroblast sample human fibroblast of gingiva sample human fibroblast of periodontium sample granulocyte macrophage progenitor cell sample human hepatocyte sample human mesenchymal stem cell of umbilical cord-Sciencell sample human mesenchymal stem cell of adipose sample human mesenchymal stem cell of bone marrow sample mouse sample mouse granule cell sample mouse hepatocyte sample human neutrophil sample human osteoblast-Sciencell sample human osteoblast-Cell applications sample human renal glomerular endothelial cell sample human retinal pigment epithelial cell sample human skeletal muscle cell sample human aortic smooth muscle cell sample human smooth muscle cell of umbilical artery sample human urothelial cell sample cerebellar granule cell sample human sample mast cell- heparinase treated sample human mature adipocyte sample human cardiac mesenchymal precursor cell sample human mesenchymal precursor cell- ovarian cancer-left ovary sample human mesenchymal precursor cell- ovarian cancer-metastasis sample human mesenchymal precursor cell- ovarian cancer-right ovary sample human whole blood sample control treatment sample human adipose tissue - adult sample human brain - adult sample human parietal lobe - adult sample hippocampus - adult sample human CD14-CD16-positive Monocytes sample mouse cerebellum- embryo E13 sample mouse cerebellum- embryo E15 sample mouse cerebellum- embryo E18 sample human Monocyte-derived macrophages 0h after mock infection sample human Monocyte-derived macrophages 0h after udorn influenza infection sample human Monocyte-derived macrophages 2h after udorn influenza infection sample human Monocyte-derived macrophages 7h after udorn influenza infection sample human Monocyte-derived macrophages 24h after udorn influenza infection sample human Monocyte-derived macrophages 24h after mock infection sample mouse whole body- embryo E17.5 sample adenocarcinoma cell line sample small cell lung cancer cell sample carcinoma cell line sample teratocarcinoma cell line sample sarcoma cell line sample K-562 cell sample embryonic cell line sample epithelial cell line sample THP-1 cell sample gastrointestinal cancer cell sample acute myeloid leukemia cell line sample cervical cancer cell line sample squamous cell carcinoma cell line sample mesothelioma cell line sample NCI cell sample human nasal epithelial cell sample macrophage, TB infection sample iPS differentiation to neuron, control sample iPS differentiation to neuron, down-syndrome donor sample myoblast differentiation to myotubes, control sample H1 embryonic stem cells differentiation to CD34+ HSC sample 293SLAM rinderpest infection sample COBL-a rinderpest infection sample partial hepatectomy sample sham operation sample ES-OS25 embryonic stem cells sample ES-OS25 embryonic stem cells, untreated sample ES-46C embryonic stem cells, neuronal differentiation sample ES-OS25 embryonic stem cells, KD for exosomal component EXOSC3, biol_rep1 sample ARPE-19 EMT induced with TGF-beta and TNF-alpha sample hIPS sample

		Promoter select All p1@JUN p2@JUN p3@JUN p4@JUN p6@JUN
Sample		p1@JUN	p2@JUN	p3@JUN	p4@JUN	p6@JUN
293SLAM rinderpest infection, 00hr, biol_rep1	13541-145H4	311.49	36.04	48.70	8.38	3.12
293SLAM rinderpest infection, 00hr, biol_rep2	13542-145H5	315.01	36.62	57.46	8.09	3.44
293SLAM rinderpest infection, 00hr, biol_rep3	13543-145H6	329.09	34.72	50.54	10.22	3.86
293SLAM rinderpest infection, 06hr, biol_rep1	13544-145H7	297.52	35.14	44.70	8.52	2.08
293SLAM rinderpest infection, 06hr, biol_rep2	13545-145H8	317.88	36.22	45.44	7.20	3.82
293SLAM rinderpest infection, 06hr, biol_rep3	13546-145H9	287.03	31.20	47.10	7.75	2.71
293SLAM rinderpest infection, 12hr, biol_rep1	13547-145I1	159.05	40.31	31.81	7.41	1.74
293SLAM rinderpest infection, 12hr, biol_rep2	13548-145I2	194.99	27.13	32.22	6.06	0.73
293SLAM rinderpest infection, 12hr, biol_rep3	13549-145I3	172.90	33.34	30.56	6.84	2.35
293SLAM rinderpest infection, 24hr, biol_rep1	13550-145I4	464.86	91.58	63.18	21.45	4.64
293SLAM rinderpest infection, 24hr, biol_rep2	13551-145I5	461.64	96.21	74.78	20.62	5.26
293SLAM rinderpest infection, 24hr, biol_rep3	13552-145I6	421.19	97.57	59.76	20.73	5.29
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep1	13625-146H7	24.82	7.25	2.42	1.61	0.16
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep2	13626-146H8	16.99	6.62	0.90	0.60	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep3	13627-146H9	23.49	7.46	1.98	0.88	0.22
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep1	13628-146I1	39.99	9.31	10.31	2.51	0.50
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep2	13629-146I2	37.35	7.43	7.64	0.66	0.66
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep3	13630-146I3	37.54	10.12	8.44	1.27	0.42
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep1	13631-146I4	85.30	19.19	15.99	4.27	1.07
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep2	13632-146I5	86.50	18.65	25.27	4.36	0.45
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep3	13633-146I6	92.49	15.10	21.12	3.61	0.40
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep1	13634-146I7	97.36	20.37	25.03	3.63	0.69
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep2	13635-146I8	84.79	13.57	19.91	4.65	0.65
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep3	13636-146I9	85.18	19.17	17.47	2.18	0.97
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep1	13637-147A1	53.40	14.19	13.42	2.58	0.26
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep2	13638-147A2	72.16	12.98	12.03	4.43	0.95
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep3	13639-147A3	60.44	12.64	12.09	2.75	0.55
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep1	13640-147A4	37.96	10.84	5.42	3.30	0.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep2	13641-147A5	35.05	9.69	5.49	1.62	0.48
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep3	13642-147A6	34.02	12.49	4.52	1.45	0.18
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep1	13643-147A7	20.52	7.33	2.51	0.63	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep2	13644-147A8	25.01	6.25	2.54	0.59	0.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep3	13645-147A9	27.43	9.07	3.59	1.06	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep1	13646-147B1	25.90	12.54	4.12	0.82	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep2	13647-147B2	25.99	7.48	4.11	0.56	0.19
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep3	13648-147B3	25.87	9.20	4.60	1.34	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep1	13649-147B4	20.44	7.77	3.88	0.61	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep2	13650-147B5	19.95	8.46	2.22	0.60	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep3	13651-147B6	22.15	10.53	3.24	0.54	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep1	13652-147B7	21.13	8.40	2.40	0.72	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep2	13653-147B8	21.17	6.35	1.18	0.24	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep3	13654-147B9	19.32	10.25	1.76	0.88	0.15
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep1	13655-147C1	13.92	8.65	2.53	0.21	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep2	13656-147C2	18.01	6.12	1.92	0.52	0.35
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep3	13657-147C3	17.87	9.44	1.81	1.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep1	13658-147C4	15.82	6.75	2.33	0.23	0.23
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep2	13659-147C5	17.75	3.36	2.16	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep3	13660-147C6	12.52	6.26	2.09	0.30	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep1	13661-147C7	10.05	6.94	2.15	1.20	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep2	13662-147C8	14.15	4.25	2.63	1.01	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep3	13663-147C9	17.01	7.99	1.23	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep1	13664-147D1	20.01	6.67	1.78	0.67	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep2	13665-147D2	0.00	13.99	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep3	13666-147D3	12.07	7.10	3.19	0.71	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep1	13667-147D4	14.25	3.98	1.66	0.99	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep2	13668-147D5	18.46	11.75	0.84	0.84	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep3	13669-147D6	13.78	6.89	1.38	0.46	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep1	13670-147D7	13.94	5.83	0.65	0.97	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep2	13671-147D8	14.45	4.82	0.64	0.32	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep3	13672-147D9	19.80	8.80	1.89	0.63	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep2	13674-147E2	7.76	0.71	1.41	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep3	13675-147E3	11.22	0.56	0.00	0.56	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep1	13676-147E4	11.94	5.57	3.18	0.80	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep2	13677-147E5	10.53	6.12	0.68	0.68	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep3	13678-147E6	5.85	2.92	0.65	0.32	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep1	13679-147E7	11.36	2.84	1.77	0.35	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep2	13680-147E8	0.00	16.16	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep3	13681-147E9	23.69	7.90	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep1	13682-147F1	14.14	1.46	0.49	0.49	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep2	13683-147F2	15.87	1.98	0.50	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep3	13684-147F3	19.70	5.16	2.35	0.47	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep1	13685-147F4	22.85	5.30	1.32	0.99	0.33
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep2	13686-147F5	12.99	0.93	2.17	0.31	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep3	13687-147F6	10.70	2.14	2.14	0.61	0.31
Adipocyte - breast, donor1	11376-118A8	10.29	2.22	0.16	0.16	0.16
Adipocyte - breast, donor2	11327-117E4	7.22	2.09	0.48	0.16	0.00
Adipocyte - omental, donor1	11473-119C6	10.18	2.29	1.65	0.51	0.00
Adipocyte - omental, donor2	11474-119C7	3.74	1.49	0.00	0.00	0.00
Adipocyte - omental, donor3	11475-119C8	7.03	1.34	0.33	0.00	0.00
Adipocyte - perirenal, donor1	11476-119C9	5.74	3.19	0.64	0.64	0.00
Adipocyte - subcutaneous, donor1	11259-116F8	9.90	2.20	0.00	1.10	0.00
Adipocyte - subcutaneous, donor2	11336-117F4	34.78	9.94	2.26	0.00	0.00
Adipocyte - subcutaneous, donor3	11408-118E4	11.82	7.65	0.70	0.35	0.00
Adipocyte differentiation, day04, donor1	13019-139D4	15.84	6.65	0.98	0.00	0.20
Adipocyte differentiation, day04, donor2	13022-139D7	9.52	6.69	0.26	0.26	0.00
Adipocyte differentiation, day04, donor3	13025-139E1	11.99	11.99	1.12	0.28	0.00
Adipocyte differentiation, day04, donor4	13028-139E4	6.47	2.94	0.00	0.00	0.00
Adipocyte differentiation, day08, donor1	13020-139D5	5.47	3.22	0.80	0.00	0.00
Adipocyte differentiation, day08, donor2	13023-139D8	9.68	6.78	1.94	0.32	0.00
Adipocyte differentiation, day08, donor3	13026-139E2	16.53	10.66	4.27	0.53	0.00
Adipocyte differentiation, day08, donor4	13029-139E5	6.68	2.23	0.56	0.56	0.00
Adipocyte differentiation, day12, donor1	13021-139D6	9.57	1.66	0.83	0.42	0.00
Adipocyte differentiation, day12, donor2	13024-139D9	14.07	5.78	0.50	0.00	0.00
Adipocyte differentiation, day12, donor3	13027-139E3	7.53	3.27	0.00	0.00	0.33
Adipocyte differentiation, day12, donor4	13030-139E6	6.70	1.52	0.61	0.30	0.00
Alveolar Epithelial Cells, donor1	11510-119G7	29.61	16.35	4.42	0.00	0.22
Alveolar Epithelial Cells, donor2	11590-120G6	29.40	15.06	8.25	0.72	0.00
Alveolar Epithelial Cells, donor3	11671-122G6	14.38	7.19	1.20	1.20	0.00
Amniotic Epithelial Cells, donor1	11533-120A3	66.57	32.20	4.86	2.34	0.72
Amniotic Epithelial Cells, donor2	11613-122A2	135.55	71.96	15.06	6.69	0.00
Amniotic Epithelial Cells, donor3	11694-123A2	66.36	31.43	6.99	1.85	0.82
Anulus Pulposus Cell, donor1	11248-116E6	148.75	36.85	27.12	3.66	1.37
Anulus Pulposus Cell, donor2	11463-119B5	139.60	21.80	32.57	1.71	0.73
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep1 (LK1)	12642-134G5	22.02	13.48	4.94	0.90	0.00
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep2 (LK2)	12740-135I4	25.61	13.02	4.34	0.87	0.87
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep3 (LK3)	12838-137B3	32.10	6.42	0.00	2.14	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep1 (LK4)	12643-134G6	25.71	12.26	6.58	1.79	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep2 (LK5)	12741-135I5	25.29	12.65	3.79	1.26	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep3 (LK6)	12839-137B4	27.72	7.26	1.32	0.66	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep1 (LK7)	12644-134G7	22.09	8.77	4.22	1.95	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep2 (LK8)	12742-135I6	21.36	11.65	6.31	3.40	0.49
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep3 (LK9)	12840-137B5	25.54	7.72	3.56	2.38	0.59
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep1 (LK10)	12645-134G8	24.48	9.42	4.14	2.26	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep2 (LK11)	12743-135I7	22.50	10.16	2.90	2.18	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep3 (LK12)	12841-137B6	25.08	5.02	2.51	2.51	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep1 (LK13)	12646-134G9	22.24	8.24	2.14	1.15	0.16
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep2 (LK14)	12744-135I8	6.82	13.65	2.73	1.36	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep3 (LK15)	12842-137B7	22.47	6.18	4.52	1.81	0.45
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep1 (LK16)	12647-134H1	21.97	7.50	1.61	2.14	0.00
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep2 (LK17)	12745-135I9	30.04	14.55	5.29	1.51	0.19
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep3 (LK18)	12843-137B8	26.73	11.76	1.87	1.87	0.53
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep1 (LK19)	12648-134H2	9.75	14.63	2.93	1.95	0.00
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep2 (LK20)	12746-136A1	27.04	14.93	4.98	1.66	0.17
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep3 (LK21)	12844-137B9	19.21	10.81	1.20	0.00	2.40
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep1 (LK22)	12649-134H3	14.16	10.62	7.08	0.00	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep2 (LK23)	12747-136A2	29.85	15.44	4.97	1.03	0.34
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep3 (LK24)	12845-137C1	12.58	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep1 (LK25)	12650-134H4	20.87	15.05	0.97	0.00	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep2 (LK26)	12748-136A3	27.32	9.11	3.04	0.38	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep3 (LK27)	12846-137C2	26.65	9.69	1.21	0.00	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep1 (LK28)	12651-134H5	24.51	6.84	2.28	0.57	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep2 (LK29)	12749-136A4	26.29	11.76	3.63	0.86	0.21
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep3 (LK30)	12847-137C3	24.00	9.81	3.36	2.06	0.52
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep1 (LK31)	12652-134H6	19.71	8.45	5.16	0.00	0.47
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep2 (LK32)	12750-136A5	24.76	13.18	3.86	2.25	0.00
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep3 (LK33)	12848-137C4	22.12	12.84	2.85	1.43	0.71
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep1 (LK34)	12653-134H7	19.30	17.55	4.68	0.58	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep2 (LK35)	12751-136A6	23.48	13.85	4.22	1.20	0.60
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep3 (LK36)	12849-137C5	23.76	10.69	3.56	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep1 (LK37)	12654-134H8	23.39	8.65	3.56	3.05	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep2 (LK38)	12752-136A7	24.70	9.42	8.40	2.55	0.51
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep3 (LK39)	12850-137C6	19.06	10.17	0.64	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep1 (LK40)	12655-134H9	29.34	9.93	6.04	2.16	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep2 (LK41)	12753-136A8	23.07	6.77	6.56	2.54	0.21
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep3 (LK42)	12851-137C7	20.88	8.99	3.19	1.74	0.29
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep1 (LK43)	12656-134I1	14.17	7.56	4.72	0.94	0.00
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep2 (LK44)	12754-136A9	27.97	9.66	6.44	2.03	0.68
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep3 (LK45)	12852-137C8	25.48	0.00	2.32	2.32	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep1 (LK46)	12657-134I2	21.13	6.34	4.23	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep2 (LK47)	12755-136B1	42.24	17.37	5.36	1.93	0.43
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep3 (LK48)	12853-137C9	24.07	20.46	1.80	0.60	0.60
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep1 (LK49)	12658-134I3	32.80	13.12	5.83	2.19	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep2 (LK50)	12756-136B2	34.94	18.16	5.98	0.69	0.23
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep3 (LK51)	12854-137D1	40.80	10.20	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep1 (LK52)	12659-134I4	30.51	9.92	4.07	1.02	1.02
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep2 (LK53)	12757-136B3	33.86	20.64	4.95	1.03	0.21
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep3 (LK54)	12855-137D2	28.76	14.08	2.75	2.45	0.61
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep1 (LK55)	12660-134I5	24.38	11.47	5.26	1.91	0.96
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep2 (LK56)	12758-136B4	26.61	14.41	4.66	1.11	1.11
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep3 (LK57)	12856-137D3	18.31	16.78	4.58	0.00	1.53
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep1 (LK58)	12661-134I6	23.82	15.51	4.98	1.66	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep2 (LK59)	12759-136B5	27.54	14.83	3.97	0.79	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep3 (LK60)	12857-137D4	22.17	16.36	4.36	1.45	0.36
Astrocyte - cerebellum, donor1	11500-119F6	41.88	50.72	3.68	1.23	0.00
Astrocyte - cerebellum, donor2	11580-120F5	35.77	24.30	4.79	0.86	0.00
Astrocyte - cerebellum, donor3	11661-122F5	39.01	54.95	2.94	1.05	0.00
Astrocyte - cerebral cortex, donor1	11235-116D2	29.98	34.51	2.79	1.05	0.00
Astrocyte - cerebral cortex, donor2	11316-117D2	37.53	40.93	3.88	1.29	0.16
Astrocyte - cerebral cortex, donor3	11392-118C6	41.47	21.03	4.18	1.04	0.00
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep1	10821-111C2	3.56	1.38	0.11	0.11	0.00
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep2	10822-111C3	3.26	1.63	0.25	0.13	0.13
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep3	10823-111C4	2.50	1.02	0.00	0.11	0.00
Basophils, donor1	12241-129G9	442.51	59.89	95.20	11.77	1.57
Basophils, donor2	12242-129H1	464.70	60.61	79.37	19.12	0.72
Basophils, donor3	12243-129H2	512.14	33.22	94.67	8.08	1.03
Bronchial Epithelial Cell, donor1	11511-119G8	23.29	14.88	2.16	0.43	0.00
Bronchial Epithelial Cell, donor2	11591-120G7	38.86	26.06	3.66	0.91	0.00
Bronchial Epithelial Cell, donor3	11672-122G7	21.52	7.17	7.17	0.00	0.00
Bronchial Epithelial Cell, donor4	11453-119A4	14.44	6.90	4.39	0.63	0.00
Bronchial Epithelial Cell, donor5	11457-119A8	22.25	10.81	2.70	1.66	0.00
Bronchial Epithelial Cell, donor6	11461-119B3	18.65	7.60	3.22	0.69	0.00
Bronchial Epithelial Cell, donor7	11769-123I5	37.25	10.98	5.58	0.90	0.36
Burkitt's lymphoma cell line:DAUDI	10422-106C8	6.29	0.52	0.21	1.24	0.00
Burkitt's lymphoma cell line:RAJI	10476-106I8	5.82	0.70	0.70	1.16	0.23
CD133+ stem cells - adult bone marrow derived, pool1	12224-129F1	147.10	11.83	19.51	2.88	0.00
CD133+ stem cells - cord blood derived, pool1	12223-129E9	258.55	31.03	31.03	0.00	0.00
CD14+ Monocytes, donor1	11224-116B9	267.69	24.23	42.83	7.33	0.00
CD14+ Monocytes, donor2	11305-117B9	253.53	28.40	55.12	10.21	0.93
CD14+ Monocytes, donor3	11381-118B4	410.31	38.64	66.08	10.54	1.76
CD14+ monocyte derived endothelial progenitor cells, donor1	11229-116C5	4.53	0.57	0.28	0.00	0.00
CD14+ monocyte derived endothelial progenitor cells, donor2	11310-117C5	10.61	5.31	0.76	0.38	0.00
CD14+ monocyte derived endothelial progenitor cells, donor3	11386-118B9	4.27	0.99	0.00	0.00	0.00
CD14+ monocytes - mock treated, donor1	11863-125A9	22.41	6.50	2.60	0.43	0.00
CD14+ monocytes - mock treated, donor2	11873-125C1	27.16	4.53	3.02	1.21	0.00
CD14+ monocytes - mock treated, donor3	11883-125D2	49.98	6.40	7.34	0.47	0.00
CD14+ monocytes - treated with B-glucan, donor1	11869-125B6	27.12	6.53	1.51	0.50	0.17
CD14+ monocytes - treated with B-glucan, donor2	11879-125C7	48.85	8.56	2.21	1.38	0.55
CD14+ monocytes - treated with B-glucan, donor3	11889-125D8	77.11	14.13	8.43	0.99	0.50
CD14+ monocytes - treated with BCG, donor1	11860-125A6	170.74	46.40	18.41	2.94	1.17
CD14+ monocytes - treated with BCG, donor2	11870-125B7	109.86	32.94	13.89	1.60	0.71
CD14+ monocytes - treated with BCG, donor3	11880-125C8	196.08	37.00	24.37	4.13	0.87
CD14+ monocytes - treated with Candida, donor1	11868-125B5	116.83	26.22	12.17	2.34	0.23
CD14+ monocytes - treated with Candida, donor2	11878-125C6	99.27	16.37	11.09	1.06	1.58
CD14+ monocytes - treated with Candida, donor3	11888-125D7	158.64	17.75	19.97	3.33	2.22
CD14+ monocytes - treated with Cryptococcus, donor1	11867-125B4	41.05	10.86	4.91	1.64	0.15
CD14+ monocytes - treated with Cryptococcus, donor2	11877-125C5	49.09	12.57	4.59	1.20	0.60
CD14+ monocytes - treated with Cryptococcus, donor3	11887-125D6	70.37	12.70	8.54	2.08	0.00
CD14+ monocytes - treated with Group A streptococci, donor1	11864-125B1	111.65	19.90	12.13	3.43	1.14
CD14+ monocytes - treated with Group A streptococci, donor2	11874-125C2	99.76	20.13	15.16	2.26	0.45
CD14+ monocytes - treated with Group A streptococci, donor3	11884-125D3	176.77	26.62	28.81	0.87	1.31
CD14+ monocytes - treated with IFN + N-hexane, donor1	11861-125A7	30.66	10.49	3.77	0.81	0.27
CD14+ monocytes - treated with IFN + N-hexane, donor2	11871-125B8	52.86	16.22	6.80	2.09	0.35
CD14+ monocytes - treated with IFN + N-hexane, donor3	11881-125C9	74.06	16.83	9.26	1.68	0.00
CD14+ monocytes - treated with Salmonella, donor1	11866-125B3	31.23	5.51	3.86	0.18	0.00
CD14+ monocytes - treated with Salmonella, donor2	11876-125C4	27.48	6.34	2.82	0.00	0.00
CD14+ monocytes - treated with Salmonella, donor3	11886-125D5	60.98	10.97	9.21	0.44	0.00
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor1	11862-125A8	146.13	43.07	12.38	2.96	1.39
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor2	11872-125B9	131.57	25.65	10.78	2.60	1.49
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor3	11882-125D1	198.09	32.55	18.11	3.45	1.29
CD14+ monocytes - treated with lipopolysaccharide, donor1	11865-125B2	24.98	4.91	2.05	0.41	0.00
CD14+ monocytes - treated with lipopolysaccharide, donor2	11875-125C3	36.16	7.42	3.01	0.46	0.00
CD14+ monocytes - treated with lipopolysaccharide, donor3	11885-125D4	90.48	13.92	11.14	1.39	0.00
CD14+CD16+ Monocytes, donor1	11789-124B7	18.96	0.65	2.40	0.22	0.00
CD14+CD16+ Monocytes, donor2	11801-124D1	26.10	1.39	4.62	0.46	0.00
CD14+CD16+ Monocytes, donor3	11912-125G4	28.16	1.95	5.63	0.65	0.00
CD14+CD16- Monocytes, donor1	11788-124B6	51.54	4.52	4.83	4.20	0.00
CD14+CD16- Monocytes, donor2	11799-124C8	41.74	2.62	5.41	0.87	0.17
CD14+CD16- Monocytes, donor3	11910-125G2	34.56	4.01	7.14	1.78	0.22
CD14-CD16+ Monocytes, donor1	11790-124B8	12.25	1.28	1.53	0.00	0.26
CD14-CD16+ Monocytes, donor2	11800-124C9	5.05	0.88	0.66	0.44	0.00
CD14-CD16+ Monocytes, donor3	11911-125G3	20.00	1.68	2.95	0.63	0.00
CD19+ B Cells (pluriselect), donor090309, donation1	12189-129B2	20.32	10.16	0.00	2.03	0.00
CD19+ B Cells (pluriselect), donor090309, donation2	12194-129B7	23.73	2.03	4.07	1.36	0.00
CD19+ B Cells (pluriselect), donor090309, donation3	12199-129C3	35.21	2.07	5.18	1.04	0.00
CD19+ B Cells (pluriselect), donor090325, donation1	12151-128F9	206.29	12.79	25.05	13.86	1.60
CD19+ B Cells (pluriselect), donor090325, donation2	12174-128I5	24.66	2.68	2.68	2.14	0.00
CD19+ B Cells (pluriselect), donor090612, donation1	12204-129C8	42.12	4.21	7.02	2.11	0.70
CD19+ B Cells (pluriselect), donor090612, donation2	12209-129D4	28.24	6.27	3.92	3.92	0.00
CD19+ B Cells (pluriselect), donor090612, donation3	12214-129D9	29.00	2.64	3.95	6.59	0.00
CD19+ B Cells, donor1	11544-120B5	1161.35	32.05	106.85	32.05	4.93
CD19+ B Cells, donor2	11624-122B4	525.21	18.14	68.92	18.14	0.73
CD19+ B Cells, donor3	11705-123B4	610.33	16.15	66.64	22.21	2.02
CD34 cells differentiated to erythrocyte lineage, biol_ rep1	11931-125I5	1.21	0.40	0.40	0.40	0.00
CD34 cells differentiated to erythrocyte lineage, biol_ rep2	11932-125I6	0.80	0.00	0.00	0.00	0.00
CD34+ Progenitors, donor1	11545-120B6	157.64	25.10	22.09	3.01	1.00
CD34+ Progenitors, donor2	11625-122B5	233.71	50.00	40.45	5.62	0.56
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep1	12225-129F2	68.01	2.63	12.02	3.01	0.00
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep2	12225-129F2	77.79	5.19	11.73	3.16	0.00
CD4+ T Cells, donor1	11225-116C1	1302.19	204.24	237.44	39.28	2.14
CD4+ T Cells, donor2	11306-117C1	974.88	189.22	219.84	42.87	1.84
CD4+ T Cells, donor3	11382-118B5	965.91	195.20	204.04	26.23	1.22
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor1	11793-124C2	3.06	1.53	1.02	0.00	0.26
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor2	11915-125G7	5.61	1.35	0.67	0.67	0.00
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor3	11919-125H2	6.61	0.86	0.57	0.00	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor1	11780-124A7	246.53	62.11	25.13	9.01	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor2	11796-124C5	189.63	49.16	21.77	9.83	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor3	11907-125F8	234.03	32.96	52.74	19.78	0.00
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor1	11794-124C3	7.37	1.45	1.45	1.01	0.00
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor2	11916-125G8	6.10	1.02	1.02	0.34	0.00
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor3	11920-125H3	12.25	1.77	0.64	0.81	0.00
CD4+CD25+CD45RA- memory regulatory T cells, donor1	11782-124A9	164.08	41.69	19.73	7.17	0.00
CD4+CD25+CD45RA- memory regulatory T cells, donor2	11797-124C6	103.77	25.51	7.69	5.24	0.00
CD4+CD25+CD45RA- memory regulatory T cells, donor3	11908-125F9	192.27	38.72	26.40	10.56	0.44
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor1	11791-124B9	8.43	2.53	0.42	0.42	0.00
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor2	11913-125G5	12.26	5.40	1.04	0.83	0.00
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor3	11917-125G9	9.36	3.34	0.67	1.34	0.00
CD4+CD25-CD45RA+ naive conventional T cells, donor1	11784-124B2	225.71	37.53	19.31	8.97	0.27
CD4+CD25-CD45RA+ naive conventional T cells, donor2	11795-124C4	142.03	21.44	15.01	4.82	0.00
CD4+CD25-CD45RA+ naive conventional T cells, donor3	11906-125F7	200.84	17.93	28.69	10.76	1.79
CD4+CD25-CD45RA- memory conventional T cells expanded, donor1	11792-124C1	6.12	1.11	0.74	1.48	0.00
CD4+CD25-CD45RA- memory conventional T cells expanded, donor2	11914-125G6	10.61	1.95	1.52	1.08	0.22
CD4+CD25-CD45RA- memory conventional T cells expanded, donor3	11918-125H1	8.62	1.05	1.47	1.26	0.00
CD4+CD25-CD45RA- memory conventional T cells, donor1	11786-124B4	359.99	53.09	33.37	9.10	0.00
CD4+CD25-CD45RA- memory conventional T cells, donor2	11798-124C7	316.27	47.22	37.69	10.83	0.43
CD4+CD25-CD45RA- memory conventional T cells, donor3	11909-125G1	415.33	51.43	64.06	9.59	1.31
CD8+ T Cells (pluriselect), donor090309, donation1	12186-129A8	5.94	2.97	0.49	0.49	0.00
CD8+ T Cells (pluriselect), donor090309, donation2	12191-129B4	3.69	0.00	0.00	0.00	0.00
CD8+ T Cells (pluriselect), donor090309, donation3	12196-129B9	1.40	2.79	2.79	0.00	0.00
CD8+ T Cells (pluriselect), donor090325, donation1	12148-128F6	46.80	6.09	8.58	1.94	0.00
CD8+ T Cells (pluriselect), donor090325, donation2	12171-128I2	7.85	1.72	1.72	0.25	0.00
CD8+ T Cells (pluriselect), donor090612, donation1	12201-129C5	7.70	0.00	3.08	0.00	0.00
CD8+ T Cells (pluriselect), donor090612, donation2	12206-129D1	4.30	1.07	0.36	0.00	0.00
CD8+ T Cells (pluriselect), donor090612, donation3	12211-129D6	2.77	5.54	0.00	0.00	0.00
CD8+ T Cells, donor1	11226-116C2	1578.70	153.22	302.51	51.73	6.55
CD8+ T Cells, donor2	11307-117C2	1143.19	152.43	251.91	47.30	4.88
CD8+ T Cells, donor3	11383-118B6	1366.22	139.37	288.85	43.93	4.29
COBL-a rinderpest infection, 00hr, biol_rep1	13553-145I7	37.62	13.08	3.90	1.15	0.00
COBL-a rinderpest infection, 00hr, biol_rep2	13554-145I8	24.68	11.26	3.83	0.72	0.00
COBL-a rinderpest infection, 00hr, biol_rep3	13555-145I9	26.26	10.94	1.92	1.92	0.00
COBL-a rinderpest infection, 06hr, biol_rep1	13556-146A1	71.15	19.21	7.81	2.10	0.30
COBL-a rinderpest infection, 06hr, biol_rep2	13557-146A2	51.36	19.44	8.40	3.12	0.00
COBL-a rinderpest infection, 06hr, biol_rep3	13558-146A3	42.98	18.19	7.96	2.05	0.23
COBL-a rinderpest infection, 12hr, biol_rep1	13559-146A4	53.45	16.51	8.91	4.13	0.00
COBL-a rinderpest infection, 12hr, biol_rep2	13560-146A5	46.06	12.90	5.26	5.00	0.00
COBL-a rinderpest infection, 12hr, biol_rep3	13561-146A6	62.85	17.12	7.97	2.11	0.00
COBL-a rinderpest infection, 24hr, biol_rep1	13562-146A7	70.34	12.08	5.74	1.81	0.30
COBL-a rinderpest infection, 24hr, biol_rep2	13563-146A8	46.48	17.14	6.39	1.45	0.29
COBL-a rinderpest infection, 24hr, biol_rep3	13564-146A9	53.02	12.79	11.99	2.13	0.27
COBL-a rinderpest infection, 48hr, biol_rep1	13565-146B1	270.09	46.40	43.34	7.44	2.19
COBL-a rinderpest infection, 48hr, biol_rep2	13566-146B2	268.25	44.63	40.53	6.38	1.37
COBL-a rinderpest infection, 48hr, biol_rep3	13567-146B3	176.77	32.82	30.58	5.22	1.49
COBL-a rinderpest(-C) infection, 06hr, biol_rep1	13568-146B4	64.47	18.37	8.64	5.04	1.08
COBL-a rinderpest(-C) infection, 06hr, biol_rep2	13569-146B5	72.22	22.44	10.07	4.32	0.29
COBL-a rinderpest(-C) infection, 06hr, biol_rep3	13570-146B6	40.07	18.15	9.43	2.12	0.71
COBL-a rinderpest(-C) infection, 12hr, biol_rep1	13571-146B7	72.25	20.28	13.94	3.80	0.32
COBL-a rinderpest(-C) infection, 12hr, biol_rep2	13572-146B8	73.51	17.22	14.76	2.77	0.92
COBL-a rinderpest(-C) infection, 12hr, biol_rep3	13573-146B9	69.25	18.91	8.34	2.24	0.96
COBL-a rinderpest(-C) infection, 24hr, biol_rep1	13574-146C1	71.90	25.63	21.42	2.68	0.76
COBL-a rinderpest(-C) infection, 24hr, biol_rep2	13575-146C2	92.22	23.25	18.92	5.52	0.79
COBL-a rinderpest(-C) infection, 24hr, biol_rep3	13576-146C3	59.76	24.96	12.86	6.05	0.76
COBL-a rinderpest(-C) infection, 48hr, biol_rep1	13577-146C4	642.36	109.20	91.54	15.26	0.80
COBL-a rinderpest(-C) infection, 48hr, biol_rep2	13578-146C5	574.23	105.61	89.53	14.69	1.40
COBL-a rinderpest(-C) infection, 48hr, biol_rep3	13579-146C6	578.01	99.17	122.21	14.02	2.00
Cardiac Myocyte, donor1	11525-119I4	20.11	5.48	5.48	0.00	0.00
Cardiac Myocyte, donor2	11605-120I3	18.28	4.94	4.94	0.99	0.00
Cardiac Myocyte, donor3	11686-122I3	19.36	7.89	7.79	1.05	0.00
Chondrocyte - de diff, donor1	11261-116G1	21.84	7.63	7.28	0.35	0.35
Chondrocyte - de diff, donor2	11338-117F6	9.95	4.98	2.84	0.00	0.00
Chondrocyte - de diff, donor3	11410-118E6	18.20	5.01	3.07	0.57	0.00
Chondrocyte - re diff, donor2	11339-117F7	17.91	2.69	1.79	2.69	0.00
Chondrocyte - re diff, donor3	11411-118E7	52.98	6.07	11.73	0.81	0.00
Ciliary Epithelial Cells, donor1	11242-116D9	40.85	28.35	3.33	1.26	0.11
Ciliary Epithelial Cells, donor2	11323-117D9	27.36	17.32	3.63	1.28	0.21
Ciliary Epithelial Cells, donor3	11399-118D4	43.01	17.61	6.64	1.77	0.09
Clontech Human Universal Reference Total RNA, pool1	10000-101A1	83.08	11.19	11.46	2.02	0.28
Corneal Epithelial Cells, donor1	11526-119I5	18.66	13.17	1.32	0.44	0.22
Corneal Epithelial Cells, donor2	11606-120I4	5.69	5.69	2.28	0.00	0.00
Corneal Epithelial Cells, donor3	11687-122I4	12.01	8.18	1.53	0.77	0.00
Dendritic Cells - monocyte immature derived, donor1, rep2	11227-116C3	55.80	30.38	3.80	2.81	0.66
Dendritic Cells - monocyte immature derived, donor1, tech_rep1	11227-116C3	61.82	28.39	4.42	1.26	0.00
Dendritic Cells - monocyte immature derived, donor2	11308-117C3	51.76	31.06	3.45	0.00	0.00
Dendritic Cells - monocyte immature derived, donor3	11384-118B7	91.68	22.14	7.02	1.30	0.76
Dendritic Cells - plasmacytoid, donor1	11228-116C4	36.90	2.73	2.05	0.34	0.00
Dendritic Cells - plasmacytoid, donor2	11309-117C4	24.16	1.96	1.96	0.65	0.00
Dendritic Cells - plasmacytoid, donor3	11385-118B8	29.52	4.36	2.42	0.48	0.00
Endothelial Cells - Aortic, donor0	11207-116A1	44.03	15.84	3.34	1.33	0.33
Endothelial Cells - Aortic, donor1	11263-116G3	42.83	11.15	2.35	0.59	0.00
Endothelial Cells - Aortic, donor2	11340-117F8	49.77	13.01	7.64	1.98	0.28
Endothelial Cells - Aortic, donor3	11412-118E8	16.91	10.62	5.50	0.79	0.00
Endothelial Cells - Artery, donor1	11264-116G4	41.89	12.22	4.36	1.16	0.29
Endothelial Cells - Artery, donor2	11341-117F9	38.59	13.88	5.65	2.35	0.24
Endothelial Cells - Artery, donor3	11413-118E9	49.79	13.85	5.79	1.40	0.18
Endothelial Cells - Lymphatic, donor1	11236-116D3	45.00	11.53	4.65	0.89	0.22
Endothelial Cells - Lymphatic, donor2	11317-117D3	36.82	11.26	8.52	1.22	0.30
Endothelial Cells - Lymphatic, donor3	11393-118C7	23.96	10.99	3.10	0.56	0.28
Endothelial Cells - Microvascular, donor1	11265-116G5	30.60	7.13	3.86	1.49	0.00
Endothelial Cells - Microvascular, donor2	11342-117G1	19.26	1.56	3.12	0.52	0.00
Endothelial Cells - Microvascular, donor3	11414-118F1	33.32	7.51	3.40	0.43	0.14
Endothelial Cells - Thoracic, donor1	11266-116G6	23.21	15.60	5.60	0.40	0.40
Endothelial Cells - Thoracic, donor2	11343-117G2	32.50	9.96	4.72	0.52	0.00
Endothelial Cells - Umbilical vein, donor1	11243-116E1	29.69	8.82	3.98	1.24	0.12
Endothelial Cells - Umbilical vein, donor2	11324-117E1	10.21	2.61	0.43	0.43	0.00
Endothelial Cells - Umbilical vein, donor3	11400-118D5	17.46	4.40	0.98	0.12	0.00
Endothelial Cells - Vein, donor1	11267-116G7	44.36	7.96	2.28	0.00	1.14
Endothelial Cells - Vein, donor2	11344-117G3	55.88	20.26	6.99	2.10	0.70
Endothelial Cells - Vein, donor3	11416-118F3	61.39	18.21	7.69	1.88	0.63
Eosinophils, donor1	12244-129H3	152.47	30.49	15.25	0.00	0.00
Eosinophils, donor2	12245-129H4	110.57	33.01	26.40	6.60	1.65
Eosinophils, donor3	12246-129H5	167.64	42.80	49.94	7.13	0.00
Esophageal Epithelial Cells, donor1	11507-119G4	24.43	15.39	2.44	1.22	0.00
Esophageal Epithelial Cells, donor2	11587-120G3	37.44	10.40	6.24	2.08	0.00
Esophageal Epithelial Cells, donor3	11668-122G3	32.54	32.54	16.27	0.00	0.00
Ewing's sarcoma cell line:Hs 863.T	10705-109H3	18.88	1.23	4.52	3.69	0.82
Fibroblast - Aortic Adventitial donor2 (cytoplasmic fraction)	14331-155F2	24.63	5.47	3.18	1.97	0.66
Fibroblast - Aortic Adventitial donor3 (cytoplasmic fraction)	14310-155C8	21.99	5.09	2.93	0.98	0.00
Fibroblast - Aortic Adventitial, donor1	11245-116E3	19.28	4.24	3.52	2.18	0.00
Fibroblast - Aortic Adventitial, donor2 (nuclear fraction)	14332-155F3	84.61	19.11	37.39	6.00	1.64
Fibroblast - Aortic Adventitial, donor2	11326-117E3	21.20	6.33	4.22	0.84	0.00
Fibroblast - Aortic Adventitial, donor3 (nuclear fraction)	14311-155C9	33.46	10.28	12.12	2.63	0.53
Fibroblast - Aortic Adventitial, donor3	11401-118D6	28.57	5.32	4.65	1.66	0.33
Fibroblast - Cardiac, donor1	11268-116G8	15.42	4.99	4.99	0.00	0.00
Fibroblast - Cardiac, donor2	11345-117G4	15.16	6.82	1.52	0.00	0.00
Fibroblast - Cardiac, donor3	11417-118F4	17.82	4.42	3.15	1.58	0.00
Fibroblast - Cardiac, donor4	11452-119A3	14.55	5.46	3.33	1.82	0.00
Fibroblast - Cardiac, donor5	11456-119A7	16.50	7.36	2.79	0.38	0.13
Fibroblast - Cardiac, donor6	11460-119B2	10.76	6.22	0.91	0.30	0.00
Fibroblast - Choroid Plexus, donor1	11492-119E7	20.10	15.68	2.14	0.67	0.00
Fibroblast - Choroid Plexus, donor2	11572-120E6	44.44	16.39	3.88	1.29	0.43
Fibroblast - Choroid Plexus, donor3	11653-122E6	20.51	11.72	8.79	0.00	0.00
Fibroblast - Conjunctival, donor1	11531-120A1	14.76	9.46	1.38	0.46	0.00
Fibroblast - Conjunctival, donor3	11692-122I9	55.12	33.58	8.48	1.70	0.17
Fibroblast - Dermal, donor1	11269-116G9	60.57	12.91	6.57	0.70	0.00
Fibroblast - Dermal, donor2	11346-117G5	30.66	16.51	1.42	0.47	0.47
Fibroblast - Dermal, donor3	11418-118F5	28.65	7.01	3.26	0.85	0.12
Fibroblast - Dermal, donor4	11450-119A1	18.31	12.43	2.71	0.90	0.00
Fibroblast - Dermal, donor5	11454-119A5	26.34	15.53	2.97	1.22	0.00
Fibroblast - Dermal, donor6	11458-119A9	21.93	10.56	3.09	1.62	0.00
Fibroblast - Gingival, donor1	11237-116D4	14.37	7.50	0.83	0.62	0.00
Fibroblast - Gingival, donor10 (periodontitis)	11928-125I2	6.03	3.41	0.52	0.00	0.26
Fibroblast - Gingival, donor2	11318-117D4	20.16	14.23	1.58	0.79	0.13
Fibroblast - Gingival, donor3	11394-118C8	17.21	9.77	1.64	0.87	0.10
Fibroblast - Gingival, donor4 (GFH2)	11222-116B7	14.54	11.43	1.04	0.00	0.00
Fibroblast - Gingival, donor5 (GFH3)	11303-117B7	9.51	7.75	1.06	0.35	0.00
Fibroblast - Gingival, donor6 (aggressive periodontitis)	11921-125H4	15.59	7.17	0.94	0.31	0.31
Fibroblast - Gingival, donor6 (control)	11922-125H5	21.37	13.52	2.16	0.81	0.00
Fibroblast - Gingival, donor7 (aggressive periodontitis)	11923-125H6	29.29	9.88	4.94	1.41	0.35
Fibroblast - Gingival, donor7 (control)	11924-125H7	17.26	11.41	1.75	0.58	0.15
Fibroblast - Gingival, donor8 (chronic periodontitis)	11925-125H8	18.95	11.45	1.50	1.09	0.14
Fibroblast - Gingival, donor8 (control)	11926-125H9	40.59	11.08	4.72	1.10	0.22
Fibroblast - Gingival, donor9 (control)	11927-125I1	13.35	13.65	1.03	0.59	0.00
Fibroblast - Lung, donor1	11270-116H1	31.27	12.23	4.08	0.00	0.00
Fibroblast - Lung, donor2	11347-117G6	76.10	11.94	2.98	4.48	0.00
Fibroblast - Lung, donor3	11419-118F6	54.87	13.93	4.22	1.48	0.00
Fibroblast - Lymphatic, donor1	11506-119G3	29.16	19.99	5.00	0.83	0.00
Fibroblast - Lymphatic, donor2	11586-120G2	9.79	9.79	1.40	0.00	0.00
Fibroblast - Lymphatic, donor3	11667-122G2	7.28	8.68	1.12	0.56	0.00
Fibroblast - Mammary, donor1	11540-120B1	23.14	9.74	2.03	0.00	0.00
Fibroblast - Mammary, donor2	11620-122A9	27.96	11.98	3.99	0.00	0.00
Fibroblast - Mammary, donor3	11701-123A9	11.91	11.91	11.91	0.00	0.00
Fibroblast - Periodontal Ligament, donor1	11238-116D5	30.07	16.29	2.33	0.78	0.00
Fibroblast - Periodontal Ligament, donor2	11319-117D5	25.63	19.87	1.97	0.46	0.15
Fibroblast - Periodontal Ligament, donor3	11395-118C9	19.89	7.65	2.75	0.31	0.00
Fibroblast - Periodontal Ligament, donor4 (PL29)	11223-116B8	23.66	10.69	3.82	0.76	0.38
Fibroblast - Periodontal Ligament, donor5 (PL30)	11304-117B8	13.77	4.05	1.89	1.08	0.00
Fibroblast - Periodontal Ligament, donor6 (PLH3)	11380-118B3	11.71	2.32	1.16	0.00	0.00
Fibroblast - Pulmonary Artery, donor1	11250-116E8	20.23	3.98	4.20	0.66	0.11
Fibroblast - Villous Mesenchymal, donor1	11535-120A5	12.60	3.66	0.20	0.00	0.00
Fibroblast - Villous Mesenchymal, donor2	11615-122A4	28.73	26.73	0.67	0.67	0.00
Fibroblast - Villous Mesenchymal, donor3	11696-123A4	46.65	13.84	3.16	1.19	0.00
Fibroblast - skin dystrophia myotonica, donor1 (nuclear fraction)	14329-155E9	55.17	14.49	14.09	2.38	0.60
Fibroblast - skin dystrophia myotonica, donor1	11556-120C8	19.18	9.41	1.42	0.36	0.00
Fibroblast - skin dystrophia myotonica, donor2	11557-120C9	19.12	8.28	1.18	0.20	0.00
Fibroblast - skin dystrophia myotonica, donor3 (nuclear fraction)	14308-155C6	71.30	18.35	16.25	4.51	0.90
Fibroblast - skin dystrophia myotonica, donor3	11560-120D3	20.08	14.36	2.81	1.08	0.00
Fibroblast - skin normal, donor1 (nuclear fraction)	14323-155E3	93.13	16.45	24.30	5.82	0.76
Fibroblast - skin normal, donor1	11553-120C5	14.77	7.71	1.31	0.33	0.00
Fibroblast - skin normal, donor2 (nuclear fraction)	14302-155B9	82.01	18.85	17.04	7.02	1.20
Fibroblast - skin normal, donor2	11561-120D4	17.68	6.53	2.31	0.30	0.00
Fibroblast - skin spinal muscular atrophy, donor1 (nuclear fraction)	14326-155E6	85.23	26.60	20.25	6.04	1.21
Fibroblast - skin spinal muscular atrophy, donor1	11555-120C7	19.88	10.19	1.33	0.66	0.00
Fibroblast - skin spinal muscular atrophy, donor2	11558-120D1	15.56	16.92	1.71	1.20	0.00
Fibroblast - skin spinal muscular atrophy, donor3 (nuclear fraction)	14305-155C3	128.42	20.36	23.65	6.57	2.96
Fibroblast - skin spinal muscular atrophy, donor3	11559-120D2	25.25	11.29	4.15	0.85	0.32
Fibroblast - skin walker warburg, donor1	11554-120C6	20.07	7.25	2.02	0.17	0.17
Fibroblast - skin, normal donor1 (cytoplasmic fraction)	14322-155E2	21.01	6.59	1.57	0.63	0.00
Fibroblast - skin, normal donor2 (cytoplasmic fraction)	14301-155B8	88.64	88.64	0.00	0.00	0.00
Fingernail (including nail plate, eponychium and hyponychium), donor2	10301-104H4	15.69	7.84	1.74	0.00	0.00
Gingival epithelial cells, donor1 (GEA11)	11221-116B6	23.92	14.56	0.87	0.69	0.00
Gingival epithelial cells, donor2 (GEA14)	11302-117B6	24.46	14.31	3.38	0.26	0.00
Gingival epithelial cells, donor3 (GEA15)	11379-118B2	20.70	13.80	2.04	0.00	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep1	13523-145F4	10.72	7.66	0.00	0.00	0.77
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep2	13524-145F5	5.74	7.66	0.00	0.00	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep3	13525-145F6	69.03	21.97	7.99	3.42	0.29
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep1	13526-145F7	4.96	1.38	0.00	0.28	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep2	13527-145F8	23.97	8.90	2.74	0.68	0.23
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep3	13528-145F9	42.40	12.68	5.15	2.58	0.99
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep1	13529-145G1	3.70	1.06	0.26	0.26	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep2	13530-145G2	27.40	9.78	0.65	0.33	0.33
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep3	13531-145G3	46.88	10.17	4.86	3.98	0.44
H9 Embryoid body cells, melanocytic induction, day00, biol_rep1 (H9EB-1 d0)	12627-134E8	14.13	12.01	2.12	0.85	0.14
H9 Embryoid body cells, melanocytic induction, day00, biol_rep2 (H9EB-2 d0)	12725-135G7	17.36	10.84	1.48	0.74	0.00
H9 Embryoid body cells, melanocytic induction, day00, biol_rep3 (H9EB-3 d0)	12823-136I6	17.73	6.72	1.61	0.00	0.27
H9 Embryoid body cells, melanocytic induction, day01, biol_rep1 (H9EB-1 d1)	12628-134E9	38.90	17.35	3.47	1.36	0.12
H9 Embryoid body cells, melanocytic induction, day01, biol_rep2 (H9EB-2 d1)	12726-135G8	49.14	24.64	4.98	1.11	0.00
H9 Embryoid body cells, melanocytic induction, day01, biol_rep3 (H9EB-3 d1)	12824-136I7	43.51	23.99	4.68	0.61	0.20
H9 Embryoid body cells, melanocytic induction, day03, biol_rep1 (H9EB-1 d3)	12629-134F1	31.26	10.04	2.28	0.46	0.00
H9 Embryoid body cells, melanocytic induction, day03, biol_rep2 (H9EB-2 d3)	12727-135G9	25.04	11.71	2.12	0.87	0.00
H9 Embryoid body cells, melanocytic induction, day03, biol_rep3 (H9EB-3 d3)	12825-136I8	47.21	17.27	2.84	0.66	0.22
H9 Embryoid body cells, melanocytic induction, day06, biol_rep1 (H9EB-1 d6)	12630-134F2	20.39	8.27	2.07	1.18	0.00
H9 Embryoid body cells, melanocytic induction, day06, biol_rep2 (H9EB-2 d6)	12728-135H1	17.64	10.97	2.07	0.48	0.00
H9 Embryoid body cells, melanocytic induction, day06, biol_rep3 (H9EB-3 d6)	12826-136I9	25.47	6.26	1.79	0.22	0.00
H9 Embryoid body cells, melanocytic induction, day09, biol_rep1 (H9EB-1 d9)	12631-134F3	27.83	7.46	1.41	0.60	0.20
H9 Embryoid body cells, melanocytic induction, day09, biol_rep2 (H9EB-2 d9)	12729-135H2	16.29	7.97	0.85	0.34	0.17
H9 Embryoid body cells, melanocytic induction, day09, biol_rep3 (H9EB-3 d9)	12827-137A1	19.60	6.65	1.33	0.62	0.09
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	32.26	8.95	2.81	1.46	0.31
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	32.79	7.68	2.22	1.37	0.34
H9 Embryoid body cells, melanocytic induction, day12, biol_rep2 (H9EB-2 d12)	12730-135H3	20.91	6.75	1.77	1.11	0.22
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	13.48	6.49	1.25	0.83	0.08
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	13.27	4.29	0.61	0.20	0.20
H9 Embryoid body cells, melanocytic induction, day15, biol_rep1 (H9EB-1 d15)	12633-134F5	29.71	6.81	1.44	0.83	0.62
H9 Embryoid body cells, melanocytic induction, day15, biol_rep2 (H9EB-2 d15)	12731-135H4	19.60	8.19	2.88	1.15	0.12
H9 Embryoid body cells, melanocytic induction, day15, biol_rep3 (H9EB-3 d15)	12829-137A3	15.01	3.00	0.83	0.50	0.00
H9 Embryoid body cells, melanocytic induction, day18, biol_rep1 (H9EB-1 d18)	12634-134F6	31.52	5.95	2.42	1.10	0.22
H9 Embryoid body cells, melanocytic induction, day18, biol_rep2 (H9EB-2 d18)	12732-135H5	36.53	8.49	3.57	1.72	0.25
H9 Embryoid body cells, melanocytic induction, day18, biol_rep3 (H9EB-3 d18)	12830-137A4	11.99	4.38	1.46	0.16	0.16
H9 Embryoid body cells, melanocytic induction, day21, biol_rep1 (H9EB-1 d21)	12635-134F7	37.84	5.45	1.60	1.28	0.64
H9 Embryoid body cells, melanocytic induction, day21, biol_rep2 (H9EB-2 d21)	12733-135H6	21.32	6.25	1.52	0.76	0.09
H9 Embryoid body cells, melanocytic induction, day21, biol_rep3 (H9EB-3 d21)	12831-137A5	13.92	3.64	1.42	0.63	0.16
H9 Embryoid body cells, melanocytic induction, day24, biol_rep1 (H9EB-1 d24)	12636-134F8	21.89	3.95	3.65	1.52	0.30
H9 Embryoid body cells, melanocytic induction, day24, biol_rep2 (H9EB-2 d24)	12734-135H7	19.34	5.54	1.67	0.21	0.10
H9 Embryoid body cells, melanocytic induction, day24, biol_rep3 (H9EB-3 d24)	12832-137A6	15.59	3.95	0.88	0.66	0.00
H9 Embryoid body cells, melanocytic induction, day27, biol_rep1 (H9EB-1 d27)	12637-134F9	24.69	8.42	1.96	1.68	0.84
H9 Embryoid body cells, melanocytic induction, day27, biol_rep2 (H9EB-2 d27)	12735-135H8	19.44	4.26	2.41	1.11	0.09
H9 Embryoid body cells, melanocytic induction, day27, biol_rep3 (H9EB-3 d27)	12833-137A7	8.82	3.74	1.87	0.53	0.00
H9 Embryoid body cells, melanocytic induction, day30, biol_rep1 (H9EB-1 d30)	12638-134G1	12.70	3.67	0.92	0.77	0.00
H9 Embryoid body cells, melanocytic induction, day30, biol_rep2 (H9EB-2 d30)	12736-135H9	15.67	3.76	1.42	0.52	0.13
H9 Embryoid body cells, melanocytic induction, day30, biol_rep3 (H9EB-3 d30)	12834-137A8	14.10	2.44	0.54	0.54	0.27
H9 Embryoid body cells, melanocytic induction, day34, biol_rep1 (H9EB-1 d34)	12639-134G2	41.29	8.48	3.87	2.03	0.00
H9 Embryoid body cells, melanocytic induction, day34, biol_rep2 (H9EB-2 d34)	12737-135I1	41.89	9.65	2.19	1.32	0.44
H9 Embryoid body cells, melanocytic induction, day34, biol_rep3 (H9EB-3 d34)	12835-137A9	26.78	5.95	0.99	1.98	0.00
H9 Embryoid body cells, melanocytic induction, day41, biol_rep1 (H9EB-1 d41)	12640-134G3	25.59	5.67	2.37	0.79	0.00
H9 Embryoid body cells, melanocytic induction, day41, biol_rep2 (H9EB-2 d41)	12738-135I2	27.44	6.25	3.03	1.41	0.40
H9 Embryoid body cells, melanocytic induction, day41, biol_rep3 (H9EB-3 d41)	12836-137B1	25.67	13.22	0.76	0.25	0.25
H9 Embryonic Stem cells, biol_rep1 (H9ES-1)	12626-134E7	7.17	5.97	0.00	0.40	0.00
H9 Embryonic Stem cells, biol_rep2 (H9ES-2)	12724-135G6	13.25	7.70	2.00	0.31	0.00
H9 Embryonic Stem cells, biol_rep3 (H9ES-3)	12822-136I5	6.14	5.11	0.61	0.82	0.20
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep1 (UH-1)	13364-143F7	13.77	8.76	1.25	0.63	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep2 (UH-2)	13365-143F8	11.58	4.52	1.41	0.57	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep3 (UH-3)	13366-143F9	2.77	3.23	0.00	0.46	0.46
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep1	13328-143B7	9.90	9.90	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep2	13340-143D1	9.28	9.67	0.39	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep3	13352-143E4	9.63	4.81	1.60	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep1	13329-143B8	17.39	6.96	3.48	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep2	13341-143D2	2.93	3.25	0.65	0.33	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep3	13353-143E5	2.88	4.12	0.41	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep1	13330-143B9	13.33	6.66	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep2	13342-143D3	4.75	3.36	0.56	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep3	13354-143E6	2.29	5.88	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep1	13331-143C1	2.52	2.52	0.84	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep2	13343-143D4	4.13	4.45	0.00	0.32	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep3	13355-143E7	3.06	4.76	1.02	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep1	13332-143C2	6.26	4.18	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep2	13344-143D5	5.73	3.44	0.57	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep3	13356-143E8	4.44	6.22	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep1	13333-143C3	6.78	6.78	1.69	1.69	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep2	13345-143D6	5.38	2.90	0.41	0.41	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep3	13357-143E9	4.14	3.68	0.69	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep1	13334-143C4	0.00	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep2	13346-143D7	5.00	3.84	1.92	0.38	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep3	13358-143F1	1.96	4.24	0.00	0.33	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep1	13335-143C5	6.69	2.01	1.34	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep2	13347-143D8	5.39	3.08	0.77	0.39	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep3	13359-143F2	11.30	7.87	0.34	0.68	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep1	13336-143C6	12.42	9.94	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep2	13348-143D9	6.13	5.19	1.42	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep3	13360-143F3	6.64	3.62	0.60	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep1	13337-143C7	8.14	3.56	1.53	0.51	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep2	13349-143E1	9.97	3.99	0.40	0.80	0.40
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep3	13361-143F4	8.39	5.43	0.99	1.48	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep1	13338-143C8	18.89	9.44	5.90	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep2	13350-143E2	11.09	5.83	0.58	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep3	13362-143F5	24.14	11.85	3.07	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep1	13339-143C9	136.48	30.52	44.08	6.78	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep2	13351-143E3	10.74	3.58	2.98	1.79	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep3	13363-143F6	18.92	6.79	4.85	1.94	0.49
Hair Follicle Dermal Papilla Cells, donor1	11271-116H2	15.98	4.57	1.14	0.00	0.00
Hair Follicle Dermal Papilla Cells, donor2	11348-117G7	6.24	2.08	0.83	0.42	0.00
Hair Follicle Dermal Papilla Cells, donor3	11420-118F7	12.37	5.62	0.00	2.25	0.00
Hair Follicle Outer Root Sheath Cells, donor1	11504-119G1	102.76	10.47	13.64	0.95	0.00
Hair Follicle Outer Root Sheath Cells, donor2	11584-120F9	37.18	6.68	8.77	1.67	0.00
Hep-2 cells mock treated, biol_rep1	11898-125E8	4.18	1.39	0.23	0.12	0.12
Hep-2 cells mock treated, biol_rep2	11899-125E9	3.21	2.36	0.51	0.68	0.00
Hep-2 cells mock treated, biol_rep3	11900-125F1	5.69	0.68	0.00	0.23	0.00
Hep-2 cells treated with Streptococci strain 5448, biol_rep1	11890-125D9	4.59	3.94	0.33	0.22	0.00
Hep-2 cells treated with Streptococci strain 5448, biol_rep2	11891-125E1	5.59	3.22	0.21	0.43	0.00
Hep-2 cells treated with Streptococci strain 5448, biol_rep3	11892-125E2	3.44	1.72	0.00	0.22	0.00
Hep-2 cells treated with Streptococci strain JRS4, biol_rep1	11894-125E4	2.86	0.62	0.12	0.12	0.00
Hep-2 cells treated with Streptococci strain JRS4, biol_rep2	11895-125E5	3.09	0.86	0.34	0.00	0.00
Hep-2 cells treated with Streptococci strain JRS4, biol_rep3	11896-125E6	2.56	0.00	0.00	0.00	0.00
Hepatic Sinusoidal Endothelial Cells, donor1	11521-119H9	27.98	8.95	3.36	0.00	0.00
Hepatic Sinusoidal Endothelial Cells, donor2	11601-120H8	29.86	6.49	1.73	0.87	0.43
Hepatic Sinusoidal Endothelial Cells, donor3	11682-122H8	18.51	42.30	2.64	2.64	0.00
Hepatic Stellate Cells (lipocyte), donor1	11524-119I3	29.98	18.34	3.88	0.00	0.00
Hepatic Stellate Cells (lipocyte), donor2	11604-120I2	25.43	10.17	6.54	0.73	0.00
Hepatic Stellate Cells (lipocyte), donor3	11685-122I2	11.19	5.59	3.15	0.52	0.17
Hepatocyte, donor1	11523-119I2	36.32	1.21	7.26	0.00	0.00
Hepatocyte, donor2	11603-120I1	31.24	3.23	3.23	0.00	0.00
Hepatocyte, donor3	11684-122I1	84.67	6.75	19.02	1.84	1.23
Hodgkin's lymphoma cell line:HD-Mar2	10435-106E3	22.84	5.22	3.26	2.61	0.00
Intestinal epithelial cells (polarized), donor1	11246-116E4	10.31	6.12	0.52	0.17	0.17
Iris Pigment Epithelial Cells, donor1	11530-119I9	32.52	22.64	4.94	1.23	0.14
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep1	13079-140B1	28.66	3.18	3.18	6.37	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep2	13145-140I4	26.70	13.35	0.00	13.35	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep3	13211-141G7	27.08	0.00	0.00	27.08	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep1	13080-140B2	27.69	4.15	9.69	1.38	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep2	13146-140I5	30.03	10.01	7.51	2.50	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep3	13212-141G8	11.87	35.60	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep1	13081-140B3	38.44	10.25	10.25	7.69	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep2	13147-140I6	54.85	9.14	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep3	13213-141G9	19.49	8.12	6.50	1.62	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep1	13082-140B4	15.01	1.67	6.67	3.33	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep2	13148-140I7	21.78	3.63	3.63	3.63	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep3	13214-141H1	21.18	6.62	9.26	1.32	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep1	13083-140B5	23.28	5.54	2.22	1.11	1.11
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep2	13149-140I8	47.14	5.24	0.00	10.48	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep3	13215-141H2	10.71	3.15	1.89	2.52	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep1	13084-140B6	35.57	7.73	7.73	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep2	13150-140I9	58.54	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep3	13216-141H3	16.80	5.17	1.29	2.58	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep1	13085-140B7	27.37	3.22	6.44	1.61	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep2	13151-141A1	35.84	35.84	11.95	0.00	11.95
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep3	13217-141H4	13.04	0.81	4.89	3.26	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep1	13086-140B8	22.25	4.20	4.20	2.52	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep2	13152-141A2	0.00	0.00	14.37	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep3	13218-141H5	8.04	3.21	3.21	1.61	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep1	13087-140B9	13.85	2.77	3.69	1.85	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep2	13153-141A3	15.08	15.08	0.00	15.08	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep3	13219-141H6	3.30	1.89	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep1	13088-140C1	7.26	3.63	1.81	0.91	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep2	13154-141A4	14.74	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep3	13220-141H7	6.46	2.15	1.08	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep1	13089-140C2	12.70	2.54	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep2	13155-141A5	32.86	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep3	13221-141H8	5.74	3.19	1.91	2.55	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep1	13090-140C3	10.94	3.65	3.65	1.82	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep2	13156-141A6	15.80	0.00	15.80	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep3	13222-141H9	7.85	5.00	1.43	2.14	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep1	13091-140C4	13.27	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep2	13157-141A7	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep3	13223-141I1	5.86	2.78	1.85	0.62	0.31
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep1	13092-140C5	19.32	7.02	8.78	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep2	13158-141A8	6.29	6.29	3.14	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep3	13224-141I2	12.52	3.48	1.39	0.70	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep1	13093-140C6	15.49	2.21	4.43	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep2	13159-141A9	19.45	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep3	13225-141I3	4.36	4.36	4.36	0.87	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep1	13094-140C7	22.50	9.00	2.25	9.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep2	13160-141B1	24.39	6.97	6.97	6.97	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep3	13226-141I4	7.47	0.00	3.20	1.07	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep1	13095-140C8	15.24	6.93	5.54	2.77	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep2	13161-141B2	8.55	0.00	2.85	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep3	13227-141I5	9.20	1.84	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep1	13096-140C9	9.08	3.03	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep2	13162-141B3	31.04	6.21	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep3	13228-141I6	10.57	1.06	0.00	3.17	0.00
Keratinocyte - epidermal, donor1	11272-116H3	35.41	23.83	2.94	1.14	0.08
Keratinocyte - epidermal, donor2	11349-117G8	11.13	5.86	0.59	1.17	0.00
Keratinocyte - epidermal, donor3	11421-118F8	21.87	10.89	2.18	0.19	0.00
Keratinocyte - oral, donor1	11251-116E9	60.28	20.43	4.65	0.57	0.00
Keratocytes, donor1	11527-119I6	27.16	7.22	2.06	0.00	0.00
Keratocytes, donor2	11607-120I5	29.30	11.72	2.34	1.17	0.00
Keratocytes, donor3	11688-122I5	15.02	4.94	0.59	0.20	0.00
Krukenberg tumor cell line:HSKTC	10687-109F3	26.37	15.39	4.40	2.20	6.59
Lens Epithelial Cells, donor1	11529-119I8	32.36	28.05	3.24	2.16	0.00
Lens Epithelial Cells, donor2	11609-120I7	50.40	40.48	5.19	1.38	0.12
Lens Epithelial Cells, donor3	11690-122I7	20.79	8.17	4.24	1.11	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep1 (MM XIX - 1)	12260-130A1	48.97	14.23	7.00	0.95	0.24
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep2 (MM XIV - 1)	12382-131E6	85.12	23.72	14.23	0.84	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep3 (MM XXII - 1 )	12504-133A2	23.30	9.92	3.78	0.31	0.16
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep1 (MM XIX - 2)	12261-130A2	55.38	12.37	8.60	1.61	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep2 (MM XIV - 2)	12383-131E7	58.31	15.44	10.72	0.32	0.32
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep3 (MM XXII - 2)	12505-133A3	23.72	8.19	3.45	1.73	0.11
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep1 (MM XIX - 3)	12262-130A3	80.85	21.34	14.36	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep2 (MM XIV - 3)	12384-131E8	110.48	34.38	17.70	2.02	0.76
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep3 (MM XXII - 3)	12506-133A4	41.10	11.26	7.04	1.13	0.56
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep1 (MM XIX - 4)	12263-130A4	72.38	22.55	9.49	1.58	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep2 (MM XIV - 4)	12385-131E9	123.70	42.46	21.91	2.33	0.58
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep3 (MM XXII - 4)	12507-133A5	32.96	10.55	7.22	0.93	0.19
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep1 (MM XIX - 5)	12264-130A5	110.80	22.30	17.77	1.05	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep2 (MM XIV - 5)	12386-131F1	136.44	32.92	22.18	2.39	0.48
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep3 (MM XXII - 5)	12508-133A6	38.59	12.09	6.04	0.69	0.41
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep1 (MM XIX - 6)	12265-130A6	86.54	22.79	12.32	0.92	0.31
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep2 (MM XIV - 6)	12387-131F2	97.89	32.42	20.89	1.25	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep3 (MM XXII - 6)	12509-133A7	27.63	10.61	3.11	0.55	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep1 (MM XIX - 7)	12266-130A7	96.10	25.67	13.49	1.32	0.66
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep2 (MM XIV - 7)	12388-131F3	126.52	37.19	16.11	2.93	0.29
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep3 (MM XXII - 7)	12510-133A8	21.16	10.95	3.98	1.24	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep1 (MM XIX - 8)	12267-130A8	90.69	24.25	11.64	0.48	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep2 (MM XIV - 8)	12389-131F4	114.18	30.97	16.97	2.42	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep3 (MM XXII - 8)	12511-133A9	32.09	11.96	4.84	0.76	0.30
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep1 (MM XIX - 9)	12268-130A9	67.91	23.33	7.26	0.52	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep2 (MM XIV - 9)	12390-131F5	133.80	46.07	25.13	1.26	0.63
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep3 (MM XXII - 9)	12512-133B1	41.80	16.39	6.32	0.75	0.15
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep1 (MM XIX - 10)	12269-130B1	30.95	12.38	5.50	1.38	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep2 (MM XIV - 10)	12391-131F6	94.07	29.35	11.48	0.75	0.56
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep3 (MM XXII - 10)	12513-133B2	27.67	9.22	3.18	0.74	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep1 (MM XIX - 11)	12270-130B2	38.28	10.66	3.39	0.48	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep2 (MM XIV - 11)	12392-131F7	64.83	22.82	10.25	0.66	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep3 (MM XXII - 11)	12514-133B3	24.41	9.54	3.59	1.36	0.12
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep1 (MM XIX - 12)	12271-130B3	26.28	11.48	1.85	1.11	0.00
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep2 (MM XIV - 12)	12393-131F8	80.55	28.66	15.57	0.74	0.25
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep3 (MM XXII - 12)	12515-133B4	32.86	14.16	6.46	0.69	0.14
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep1 (MM XIX - 13)	12272-130B4	46.32	15.76	6.75	0.64	0.00
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep2 (MM XIV - 13)	12394-131F9	61.47	19.48	6.39	0.61	0.00
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep3 (MM XXII - 13)	12516-133B5	30.09	12.74	3.22	0.98	0.00
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep1 (MM XIX - 14)	12273-130B5	41.60	9.60	6.76	1.07	0.00
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep2 (MM XIV - 14)	12395-131G1	70.29	30.54	12.12	0.97	0.00
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep3 (MM XXII - 14)	12517-133B6	26.14	9.18	3.27	0.16	0.16
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep1 (MM XIX - 15)	12274-130B6	35.09	11.82	5.73	0.36	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep2 (MM XIV - 15)	12396-131G2	58.80	22.21	10.45	1.96	0.33
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep3 (MM XXII - 15)	12518-133B7	19.30	8.95	1.88	0.71	0.24
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep1 (MM XIX - 16)	12275-130B7	35.89	13.74	3.71	0.50	0.37
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep2 (MM XIV - 16)	12397-131G3	65.82	21.26	9.73	2.05	0.00
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep3 (MM XXII - 16)	12519-133B8	29.84	8.95	2.39	0.90	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep1	13031-139E7	9.06	11.33	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep2	13097-140D1	16.11	14.58	1.53	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep3	13163-141B4	14.10	14.10	0.00	0.00	0.74
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep1	13032-139E8	26.23	36.81	2.12	0.85	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep2	13098-140D2	20.40	23.21	1.41	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep3	13164-141B5	19.61	28.02	1.87	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep1	13033-139E9	21.13	31.95	2.58	0.52	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep2	13099-140D3	29.74	24.98	3.57	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep3	13165-141B6	28.50	25.56	1.81	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep1	13034-139F1	33.15	31.70	1.16	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep2	13100-140D4	31.96	33.31	2.25	0.90	0.00
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep3	13166-141B7	40.37	48.37	3.39	0.41	0.27
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep1	13035-139F2	30.81	35.95	2.57	0.00	0.51
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep2	13101-140D5	23.29	34.58	2.82	1.06	0.00
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep3	13167-141B8	25.32	25.99	2.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep1	13036-139F3	33.11	36.68	1.53	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep2	13102-140D6	23.21	23.48	3.20	0.27	0.27
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep3	13168-141B9	19.08	30.23	1.51	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep1	13037-139F4	28.22	25.77	1.84	0.00	1.23
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep2	13103-140D7	22.02	35.88	1.63	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep3	13169-141C1	14.16	26.86	2.08	0.21	0.00
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep1	13038-139F5	13.17	19.62	1.12	0.56	0.00
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep2	13104-140D8	23.70	31.94	1.03	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep3	13170-141C2	19.45	29.03	2.03	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep1	13039-139F6	8.37	14.65	0.90	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep2	13105-140D9	16.04	23.24	1.66	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep3	13171-141C3	17.32	32.17	0.35	0.71	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep1	13040-139F7	11.80	16.96	2.95	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep2	13106-140E1	16.12	23.03	1.15	0.00	1.15
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep3	13172-141C4	19.96	29.93	1.54	0.38	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep1	13041-139F8	11.89	25.48	0.57	0.57	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep2	13107-140E2	12.31	18.05	1.64	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep3	13173-141C5	17.62	30.73	2.71	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep1	13042-139F9	15.08	25.14	0.72	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep2	13108-140E3	17.93	21.66	1.49	0.75	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep3	13174-141C6	20.81	20.44	2.23	0.74	0.00
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep1	13043-139G1	12.49	24.12	0.43	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep2	13109-140E4	14.56	22.26	3.43	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep3	13175-141C7	18.32	25.32	1.67	0.67	0.33
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep1	13044-139G2	18.10	36.80	0.00	0.60	0.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep2	13110-140E5	26.31	17.77	0.00	0.00	0.71
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep3	13176-141C8	21.31	33.34	4.12	0.34	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep1	13045-139G3	12.88	26.30	0.54	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep2	13111-140E6	22.89	18.85	2.02	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep3	13177-141C9	21.11	24.45	1.11	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep1	13046-139G4	25.58	36.05	1.16	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep2	13112-140E7	24.33	24.33	3.17	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep3	13178-141D1	19.61	22.81	2.80	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep1	13048-139G6	37.80	52.33	3.63	2.18	0.73
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep2	13114-140E9	45.99	45.22	6.13	0.77	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep3	13180-141D3	32.06	46.86	3.95	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep1	13049-139G7	34.81	52.69	3.76	0.94	0.94
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep2	13115-140F1	47.77	54.30	4.02	1.51	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep3	13181-141D4	33.35	43.26	2.25	0.45	0.90
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep1	13050-139G8	44.75	99.82	1.72	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep2	13116-140F2	62.35	75.71	7.13	1.34	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep3	13182-141D5	52.40	74.29	4.69	1.56	0.78
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep1	13051-139G9	50.14	68.61	5.28	1.32	0.66
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep2	13117-140F3	66.42	71.09	9.34	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep3	13183-141D6	58.63	85.33	8.31	2.63	0.44
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep1	13052-139H1	45.29	53.67	1.12	0.00	0.56
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep2	13118-140F4	58.74	71.10	5.30	0.00	0.44
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep3	13184-141D7	40.50	55.93	7.71	1.16	0.00
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep1	13053-139H2	33.42	64.81	3.04	0.51	0.51
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep2	13119-140F5	51.91	51.91	6.25	0.48	0.48
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep3	13185-141D8	38.56	52.87	3.98	0.40	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep1	13054-139H3	26.74	60.76	1.82	1.22	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep2	13120-140F6	29.74	40.12	2.08	0.69	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep3	13186-141D9	42.56	48.64	5.32	0.76	0.00
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep1	13055-139H4	25.30	53.71	2.07	0.52	0.52
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep2	13121-140F7	33.26	45.95	3.63	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep3	13187-141E1	28.52	43.73	4.12	0.63	0.32
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep1	13056-139H5	28.25	40.51	3.20	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep2	13122-140F8	27.58	41.38	1.15	1.15	0.00
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep3	13188-141E2	34.45	39.60	5.14	0.00	1.03
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep1	13057-139H6	16.98	39.61	1.41	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep2	13123-140F9	21.00	39.72	3.40	0.57	0.57
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep3	13189-141E3	34.11	42.02	2.50	0.42	0.00
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep1	13058-139H7	21.93	37.59	3.13	1.57	0.00
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep2	13124-140G1	17.12	31.73	1.67	0.00	0.00
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep3	13190-141E4	27.41	31.13	3.25	0.46	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep1	13059-139H8	12.04	24.75	1.34	0.67	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep2	13125-140G2	17.11	29.94	1.07	0.00	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep3	13191-141E5	18.18	27.07	2.02	0.81	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep1	13060-139H9	17.44	23.86	0.92	0.00	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep2	13126-140G3	28.45	30.23	1.78	0.00	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep3	13192-141E6	18.81	44.45	1.14	0.00	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep1	13061-139I1	8.44	31.44	0.00	0.77	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep2	13127-140G4	9.30	27.36	1.64	0.00	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep3	13193-141E7	16.93	30.29	0.89	0.00	0.00
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep1	13062-139I2	24.70	28.86	1.30	0.00	0.00
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep2	13128-140G5	15.91	29.84	1.33	0.66	0.00
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep3	13194-141E8	20.79	24.94	2.08	0.00	0.00
Macrophage - monocyte derived, donor1	11232-116C8	19.37	5.93	1.60	0.46	0.00
Macrophage - monocyte derived, donor2	11313-117C8	37.44	6.79	4.04	0.73	0.18
Macrophage - monocyte derived, donor3	11389-118C3	37.49	7.34	3.54	0.26	0.13
Mallassez-derived cells, donor1 (MZH3)	12142-128E9	26.02	10.09	1.59	1.06	0.53
Mallassez-derived cells, donor2	11929-125I3	30.90	12.04	5.70	1.74	0.16
Mallassez-derived cells, donor3	11930-125I4	32.38	15.57	2.36	0.42	0.14
Mammary Epithelial Cell, donor1	11273-116H4	21.32	6.48	3.09	0.70	0.10
Mammary Epithelial Cell, donor2	11350-117G9	19.98	3.47	3.47	0.87	0.00
Mammary Epithelial Cell, donor3	11422-118F9	20.95	6.98	2.49	0.25	0.00
Mast cell - stimulated, donor1	11487-119E2	14.91	9.49	4.07	3.39	0.00
Mast cell, donor1	11563-120D6	5.41	3.89	0.54	0.11	0.00
Mast cell, donor2	11565-120D8	2116.47	458.54	616.04	42.79	12.78
Mast cell, donor3	11566-120D9	1280.96	292.44	380.91	30.39	10.58
Mast cell, donor4	11567-120E1	1843.81	514.67	593.39	50.88	13.47
Mast cell, expanded and stimulated, donor5	11940-126A5	7.21	3.11	0.55	0.22	0.00
Mast cell, expanded and stimulated, donor8	11942-126A7	8.17	3.50	1.17	1.75	0.00
Mast cell, expanded, donor5	11939-126A4	5.28	6.31	0.46	0.69	0.00
Mast cell, expanded, donor8	11941-126A6	10.88	6.86	0.84	0.17	0.00
Melanocyte - dark, donor1	11502-119F8	28.36	4.78	5.27	0.70	0.10
Melanocyte - dark, donor2	11582-120F7	21.46	5.88	3.81	0.00	0.35
Melanocyte - dark, donor3	11663-122F7	23.54	4.13	1.81	0.58	0.00
Melanocyte - light, donor1	11274-116H5	14.57	4.23	1.18	0.47	0.00
Melanocyte - light, donor2	11351-117H1	8.19	4.09	0.68	1.36	0.00
Melanocyte - light, donor3	11423-118G1	7.81	6.94	0.00	0.00	0.00
Melanocyte, donor1 (MC+1)	12641-134G4	8.33	2.81	0.52	0.00	0.00
Melanocyte, donor2 (MC+2)	12739-135I3	4.84	3.50	0.81	0.00	0.00
Melanocyte, donor3 (MC+3)	12837-137B2	8.04	2.68	0.27	0.00	0.00
Meningeal Cells, donor1	11493-119E8	35.73	21.96	2.11	1.49	0.00
Meningeal Cells, donor2	11573-120E7	29.05	35.21	3.08	2.20	0.44
Meningeal Cells, donor3	11654-122E7	45.80	20.38	5.79	2.53	0.08
Mesenchymal Stem Cells - Vertebral, donor1	11219-116B4	45.62	13.97	7.41	1.14	0.00
Mesenchymal Stem Cells - Wharton's Jelly, donor1	11548-120B9	16.00	3.92	2.82	1.21	0.20
Mesenchymal Stem Cells - adipose, donor1	11537-120A7	30.23	13.14	1.31	0.00	0.00
Mesenchymal Stem Cells - adipose, donor2	11617-122A6	14.39	5.23	0.00	0.00	0.00
Mesenchymal Stem Cells - adipose, donor3	11698-123A6	19.38	3.59	2.87	0.00	0.00
Mesenchymal Stem Cells - amniotic membrane, donor1	11547-120B8	14.61	6.14	1.27	0.64	0.00
Mesenchymal Stem Cells - amniotic membrane, donor2	11627-122B7	19.10	3.52	2.51	0.00	0.00
Mesenchymal Stem Cells - bone marrow, donor1	11536-120A6	15.60	9.01	1.10	0.00	0.00
Mesenchymal Stem Cells - bone marrow, donor2	11616-122A5	13.88	9.50	2.19	0.00	0.00
Mesenchymal Stem Cells - bone marrow, donor3	11697-123A5	16.57	13.09	1.84	0.61	0.00
Mesenchymal Stem Cells - bone marrow, donor4	11464-119B6	111.22	13.99	25.62	5.54	0.42
Mesenchymal Stem Cells - hepatic, donor1	11538-120A8	40.89	14.87	4.83	3.35	0.37
Mesenchymal Stem Cells - hepatic, donor2	11618-122A7	87.23	15.66	23.95	4.74	1.05
Mesenchymal Stem Cells - umbilical, donor1	11539-120A9	34.72	36.80	2.67	2.08	0.00
Mesenchymal Stem Cells - umbilical, donor2	11619-122A8	28.03	23.36	2.34	0.00	0.00
Mesenchymal Stem Cells - umbilical, donor3	11700-123A8	6.40	2.56	0.00	0.00	0.00
Mesenchymal stem cells - adipose, donor0	11217-116B2	18.79	6.73	2.48	1.77	0.00
Mesenchymal stem cells - hepatic, donor0	11218-116B3	103.51	13.13	30.96	3.13	0.63
Mesenchymal stem cells - umbilical, donor0	11214-116A8	32.66	4.35	3.63	0.73	0.00
Mesothelial Cells, donor1	11247-116E5	38.72	10.61	6.89	0.80	0.00
Mesothelial Cells, donor2	12156-128G5	13.01	7.51	3.50	0.50	0.00
Mesothelial Cells, donor3	11402-118D7	26.74	9.47	7.44	0.94	0.14
Monocyte-derived macrophages response to LPS, 00hr00min, donor1 (t1 Subject1)	12698-135D7	9.45	6.75	1.35	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr00min, donor2 (t1 Subject2)	12796-136F6	18.72	6.40	2.46	0.74	0.00
Monocyte-derived macrophages response to LPS, 00hr00min, donor3 (t1 Subject3)	12894-137H5	20.61	3.83	2.65	0.59	0.29
Monocyte-derived macrophages response to LPS, 00hr15min, donor1 (t2 Subject1)	12699-135D8	13.83	6.91	0.00	3.46	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor2 (t2 Subject2)	12797-136F7	35.64	6.20	5.58	1.86	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor3 (t2 Subject3)	12895-137H6	26.55	4.56	4.77	1.04	0.62
Monocyte-derived macrophages response to LPS, 00hr30min, donor1 (t3 Subject1)	12700-135D9	23.16	2.32	4.63	0.00	4.63
Monocyte-derived macrophages response to LPS, 00hr30min, donor2 (t3 Subject2)	12798-136F8	154.41	28.78	45.55	2.75	1.50
Monocyte-derived macrophages response to LPS, 00hr30min, donor3 (t3 Subject3)	12896-137H7	47.48	13.50	15.36	0.47	0.47
Monocyte-derived macrophages response to LPS, 00hr45min, donor1 (t4 Subject1)	12701-135E1	38.93	19.47	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor2 (t4 Subject2)	12799-136F9	150.58	32.51	41.46	2.24	0.81
Monocyte-derived macrophages response to LPS, 00hr45min, donor3 (t4 Subject3)	12897-137H8	52.27	15.84	15.44	1.19	0.40
Monocyte-derived macrophages response to LPS, 01hr00min, donor1 (t5 Subject1)	12702-135E2	25.65	0.00	17.10	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor2 (t5 Subject2)	12800-136G1	99.11	15.93	25.66	1.77	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor3 (t5 Subject3)	12898-137H9	49.77	12.92	9.50	0.38	0.38
Monocyte-derived macrophages response to LPS, 01hr20min, donor1 (t6 Subject1)	12703-135E3	10.53	5.26	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor2 (t6 Subject2)	12801-136G2	50.30	11.46	10.40	1.27	0.42
Monocyte-derived macrophages response to LPS, 01hr20min, donor3 (t6 Subject3)	12899-137I1	9.21	3.68	0.00	0.92	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor1 (t7 Subject1)	12704-135E4	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor2 (t7 Subject2)	12802-136G3	30.40	6.26	8.35	0.60	0.30
Monocyte-derived macrophages response to LPS, 01hr40min, donor3 (t7 Subject3)	12900-137I2	6.71	3.35	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor1 (t8 Subject1)	12705-135E5	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor2 (t8 Subject2)	12803-136G4	16.06	8.28	7.03	0.25	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor3 (t8 Subject3)	12901-137I3	19.01	6.89	4.75	0.24	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor1 (t9 Subject1)	12706-135E6	4.98	0.55	1.11	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor2 (t9 Subject2)	12804-136G5	24.64	5.76	1.84	0.46	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor3 (t9 Subject3)	12902-137I4	12.83	5.05	3.58	0.84	0.00
Monocyte-derived macrophages response to LPS, 03hr00min, donor1 (t10 Subject1)	12707-135E7	15.69	2.85	3.06	0.20	0.00
Monocyte-derived macrophages response to LPS, 03hr00min, donor2 (t10 Subject2)	12805-136G6	25.53	3.22	2.36	0.43	0.00
Monocyte-derived macrophages response to LPS, 03hr00min, donor3 (t10 Subject3)	12903-137I5	12.45	4.89	2.67	0.22	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor1 (t11 Subject1)	12708-135E8	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor2 (t11 Subject2)	12806-136G7	23.65	4.38	1.75	0.44	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor3 (t11 Subject3)	12904-137I6	11.66	3.04	1.52	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor1 (t12 Subject1)	12709-135E9	1.66	1.66	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor2 (t12 Subject2)	12807-136G8	14.95	4.35	1.63	0.54	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor3 (t12 Subject3)	12905-137I7	17.06	5.59	2.65	0.59	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor1 (t13 Subject1)	12710-135F1	3.27	1.09	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor2 (t13 Subject2)	12808-136G9	23.07	5.29	2.40	0.48	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor3 (t13 Subject3)	12906-137I8	18.01	7.20	2.40	0.40	0.40
Monocyte-derived macrophages response to LPS, 06hr, donor1 (t14 Subject1)	12711-135F2	9.60	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor2 (t14 Subject2)	12809-136H1	29.53	6.51	4.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor3 (t14 Subject3)	12907-137I9	0.00	53.89	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor1 (t15 Subject1)	12712-135F3	6.12	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor2 (t15 Subject2)	12810-136H2	21.46	7.44	1.75	0.44	0.44
Monocyte-derived macrophages response to LPS, 07hr, donor3 (t15 Subject3)	12908-138A1	7.73	4.41	2.21	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor1 (t16 Subject1)	12713-135F4	7.04	2.56	0.64	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor2 (t16 Subject2)	12811-136H3	35.70	10.41	5.21	0.74	0.25
Monocyte-derived macrophages response to LPS, 08hr, donor3 (t16 Subject3)	12909-138A2	8.35	6.26	2.78	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor1 (t17 Subject1)	12714-135F5	2.21	4.42	2.21	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor2 (t17 Subject2)	12812-136H4	31.11	9.57	3.08	0.34	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor3 (t17 Subject3)	12910-138A3	8.31	2.63	0.88	0.44	0.44
Monocyte-derived macrophages response to LPS, 12hr, donor1 (t18 Subject1)	12715-135F6	3.55	3.91	0.36	0.00	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor2 (t18 Subject2)	12813-136H5	31.70	10.10	3.93	0.84	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor3 (t18 Subject3)	12911-138A4	9.14	4.99	2.08	0.00	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor1 (t19 Subject1)	12716-135F7	5.24	3.50	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor2 (t19 Subject2)	12814-136H6	19.61	7.24	2.11	0.90	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor3 (t19 Subject3)	12912-138A5	17.11	7.51	0.83	0.42	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor1 (t20 Subject1)	12717-135F8	14.44	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor2 (t20 Subject2)	12815-136H7	10.16	4.62	4.62	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor3 (t20 Subject3)	12913-138A6	9.68	7.40	1.71	0.57	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor1 (t21 Subject1)	12718-135F9	9.12	3.18	2.07	0.28	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor2 (t21 Subject2)	12816-136H8	23.84	8.81	2.59	0.26	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor3 (t21 Subject3)	12914-138A7	14.16	6.01	3.43	0.43	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor1 (t22 Subject1)	12719-135G1	6.35	1.27	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor2 (t22 Subject2)	12817-136H9	10.41	6.41	1.33	0.53	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor3 (t22 Subject3)	12915-138A8	31.43	9.28	2.10	0.30	0.60
Monocyte-derived macrophages response to LPS, 22hr, donor1 (t23 Subject1)	12720-135G2	9.04	5.23	0.42	0.14	0.00
Monocyte-derived macrophages response to LPS, 22hr, donor2 (t23 Subject2)	12818-136I1	18.47	10.51	1.59	0.32	0.00
Monocyte-derived macrophages response to LPS, 22hr, donor3 (t23 Subject3)	12916-138A9	21.23	10.39	4.20	0.88	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor1 (t24 Subject1)	12721-135G3	9.86	4.17	1.90	0.00	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor2 (t24 Subject2)	12819-136I2	24.15	6.82	3.41	0.85	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor3 (t24 Subject3)	12917-138B1	24.09	12.78	4.42	0.49	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor1 (t25 Subject1)	12722-135G4	2.61	3.26	0.65	0.00	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor2 (t25 Subject2)	12820-136I3	19.70	8.23	1.76	0.29	0.59
Monocyte-derived macrophages response to LPS, 36hr, donor3 (t25 Subject3)	12918-138B2	29.99	11.82	6.34	1.15	0.29
Monocyte-derived macrophages response to LPS, 48hr, donor1 (t26 Subject1)	12723-135G5	12.36	7.01	1.65	0.41	0.41
Monocyte-derived macrophages response to LPS, 48hr, donor2 (t26 Subject2)	12821-136I4	12.80	5.66	0.60	0.30	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor1 (868_121:MI_0h)	13304-142I1	22.60	3.77	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor2 (150_120:MI_0h)	13316-143A4	26.73	1.78	0.00	1.78	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor3 (536_119:MI_0h)	13322-143B1	28.59	6.57	2.30	0.99	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor4 (227_121:MI_0h)	13310-142I7	23.14	7.36	1.05	0.00	1.05
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor1 (868_121:MI_24h)	13309-142I6	20.36	5.54	0.59	0.40	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor2 (150_120:MI_24h)	13321-143A9	38.18	9.31	1.86	0.00	0.93
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor3 (536_119:MI_24h)	13327-143B6	29.67	8.64	1.50	0.75	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor4 (227_121:MI_24h)	13315-143A3	38.09	7.46	2.40	0.53	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor1 (868_121:Ud_0h)	13305-142I2	30.42	9.39	2.83	0.68	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor2 (150_120:Ud_0h)	13317-143A5	30.21	7.37	5.16	1.47	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor3 (536_119:Ud_0h)	13323-143B2	41.41	8.43	4.03	1.10	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor4 (227_121:Ud_0h)	13311-142I8	35.78	21.78	1.56	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor1 (868_121:Ud_2h)	13306-142I3	19.24	6.41	3.21	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor2 (150_120:Ud_2h)	13318-143A6	30.91	11.59	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor3 (536_119:Ud_2h)	13324-143B3	33.33	6.06	3.03	2.02	1.01
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor4 (227_121:Ud_2h)	13312-142I9	9.28	2.11	0.84	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor1 (868_121:Ud_7h)	13307-142I4	401.77	55.84	49.03	2.72	2.72
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor2 (150_120:Ud_7h)	13319-143A7	253.68	46.41	47.05	1.27	2.54
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor3 (536_119:Ud_7h)	13325-143B4	272.91	44.54	60.74	0.81	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor4 (227_121:Ud_7h)	13313-143A1	151.04	13.59	24.17	1.51	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor1 (868_121:Ud_24h)	13308-142I5	1256.24	142.75	137.04	11.42	5.71
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor2 (150_120:Ud_24h)	13320-143A8	815.61	127.24	140.29	13.05	16.31
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor3 (536_119:Ud_24h)	13326-143B5	223.37	33.27	38.02	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor4 (227_121:Ud_24h)	13314-143A2	401.57	37.65	62.75	0.00	12.55
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor1	11549-120C1	25.21	3.66	3.23	1.29	0.43
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor2	11629-122B9	12.54	2.09	1.57	0.00	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor1	13496-145C4	10.68	2.00	0.67	3.34	0.67
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor2	13505-145D4	5.84	1.67	0.42	0.00	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor3	13514-145E4	46.58	19.01	5.51	2.47	0.38
Myoblast differentiation to myotubes, day00, control donor1	13469-144I4	33.51	6.38	3.19	3.19	0.00
Myoblast differentiation to myotubes, day00, control donor2	13478-145A4	9.52	2.72	0.00	2.04	0.00
Myoblast differentiation to myotubes, day00, control donor3	13487-145B4	22.05	11.03	0.00	1.84	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor1	13497-145C5	32.65	4.19	1.67	0.00	0.84
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor2	13506-145D5	12.78	3.25	2.32	1.39	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor3	13515-145E5	25.67	5.40	1.62	1.08	0.00
Myoblast differentiation to myotubes, day01, control donor1	13470-144I5	31.12	5.05	3.36	2.73	0.63
Myoblast differentiation to myotubes, day01, control donor2	13479-145A5	33.40	0.00	11.13	0.00	0.00
Myoblast differentiation to myotubes, day01, control donor3	13488-145B5	25.81	4.96	3.47	0.00	0.50
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor1	13498-145C6	47.10	12.18	5.41	1.62	0.27
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor2	13507-145D6	21.76	3.85	2.72	2.72	0.45
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor3	13516-145E6	19.27	6.21	2.45	1.31	0.49
Myoblast differentiation to myotubes, day02, control donor1	13471-144I6	33.35	7.11	2.55	1.28	0.55
Myoblast differentiation to myotubes, day02, control donor2	13480-145A6	32.36	3.71	2.65	2.65	0.00
Myoblast differentiation to myotubes, day02, control donor3	13489-145B6	34.22	4.20	4.20	4.20	0.00
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor1	13499-145C7	62.35	23.30	5.58	1.31	0.00
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor2	13508-145D7	22.44	3.58	2.11	2.28	0.65
Myoblast differentiation to myotubes, day03, control donor1	13472-144I7	24.69	9.35	3.88	1.59	0.18
Myoblast differentiation to myotubes, day03, control donor2	13481-145A7	40.08	6.33	2.81	1.41	0.70
Myoblast differentiation to myotubes, day03, control donor3	13490-145B7	51.03	10.11	5.98	2.30	0.00
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor1	13500-145C8	35.03	12.21	4.50	1.29	0.00
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor2	13509-145D8	78.29	28.97	14.14	2.76	0.69
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor3	13518-145E8	32.87	7.59	2.53	0.00	0.00
Myoblast differentiation to myotubes, day04, control donor1	13473-144I8	22.95	9.58	3.34	1.56	0.00
Myoblast differentiation to myotubes, day04, control donor2	13482-145A8	40.22	10.16	4.66	0.00	0.00
Myoblast differentiation to myotubes, day04, control donor3	13491-145B8	55.30	15.67	4.51	0.95	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor1	13501-145C9	30.05	5.58	3.43	0.86	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor2	13510-145D9	45.14	27.08	0.00	0.00	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor3	13519-145E9	21.66	5.33	4.00	1.67	0.67
Myoblast differentiation to myotubes, day06, control donor1	13474-144I9	11.72	3.16	2.25	0.90	0.00
Myoblast differentiation to myotubes, day06, control donor2	13483-145A9	24.20	8.33	0.79	1.19	0.00
Myoblast differentiation to myotubes, day06, control donor3	13492-145B9	30.65	8.36	0.00	0.93	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor1	13502-145D1	35.95	9.46	3.03	1.14	0.38
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor2	13511-145E1	20.53	3.91	1.96	1.30	0.33
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor3	13520-145F1	12.64	4.36	1.31	0.00	0.00
Myoblast differentiation to myotubes, day08, control donor1	13475-145A1	17.19	5.88	0.90	0.90	0.45
Myoblast differentiation to myotubes, day08, control donor2	13484-145B1	22.05	7.94	3.53	2.65	0.00
Myoblast differentiation to myotubes, day08, control donor3	13493-145C1	33.91	11.30	7.98	0.00	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor1	13503-145D2	36.21	7.94	4.46	1.98	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor2	13512-145E2	21.44	6.51	4.21	0.77	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor3	13521-145F2	54.44	23.89	2.72	0.91	0.00
Myoblast differentiation to myotubes, day10, control donor1	13476-145A2	19.23	7.07	2.43	1.11	0.00
Myoblast differentiation to myotubes, day10, control donor2	13485-145B2	18.97	1.36	2.03	0.00	0.00
Myoblast differentiation to myotubes, day10, control donor3	13494-145C2	56.20	25.55	0.00	0.00	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor1	13504-145D3	26.83	9.15	7.93	0.00	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor2	13513-145E3	14.16	5.67	2.83	1.26	0.31
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor3	13522-145F3	25.42	8.78	3.63	1.21	0.00
Myoblast differentiation to myotubes, day12, control donor1	13477-145A3	43.51	6.33	3.16	3.16	0.79
Myoblast differentiation to myotubes, day12, control donor2	13486-145B3	75.95	35.14	4.53	1.13	2.27
Myoblast differentiation to myotubes, day12, control donor3	13495-145C3	55.64	55.64	0.00	5.06	0.00
Myoblast, donor1	11241-116D8	17.39	4.97	1.99	0.62	0.12
Myoblast, donor2	11322-117D8	21.86	14.38	1.73	1.15	0.19
Myoblast, donor3	11398-118D3	23.71	9.25	3.20	0.84	0.34
NK T cell leukemia cell line:KHYG-1	10777-110G3	49.33	4.38	1.90	13.13	5.69
Natural Killer Cells, donor1	11230-116C6	1343.54	146.07	219.57	35.36	5.84
Natural Killer Cells, donor2	11311-117C6	1166.72	155.30	268.08	51.57	5.73
Natural Killer Cells, donor3	11387-118C1	1504.46	129.02	296.14	39.02	5.34
Neural stem cells, donor1	11275-116H6	74.40	110.33	6.53	4.36	0.73
Neural stem cells, donor2	11352-117H2	65.47	61.62	15.41	3.85	0.00
Neurons, donor1	11494-119E9	76.24	70.55	4.55	4.55	0.00
Neurons, donor2	11574-120E8	88.07	47.56	12.33	2.86	0.22
Neurons, donor3	11655-122E8	45.22	50.15	2.47	2.47	1.64
Neutrophils, donor1	11233-116C9	9.28	3.71	0.00	0.00	0.00
Neutrophils, donor2	11314-117C9	11.60	0.00	0.00	0.00	0.00
Neutrophils, donor3	11390-118C4	22.60	3.67	2.44	0.00	0.00
Nucleus Pulposus Cell, donor1	11252-116F1	276.06	54.02	49.87	4.51	0.71
Nucleus Pulposus Cell, donor2	11409-118E5	86.28	71.31	13.35	1.63	0.33
Nucleus Pulposus Cell, donor3	11462-119B4	63.78	22.26	11.23	2.21	0.00
Olfactory epithelial cells, donor1	11933-125I7	13.21	5.23	2.06	0.41	0.14
Olfactory epithelial cells, donor2	11934-125I8	13.90	5.65	2.03	0.58	0.00
Olfactory epithelial cells, donor3	11935-125I9	14.30	3.18	2.16	1.25	0.00
Olfactory epithelial cells, donor4	11936-126A1	28.44	11.20	4.29	1.66	0.19
Oligodendrocyte - precursors, donor1	11496-119F2	60.18	12.64	13.84	2.41	0.00
Osteoblast - differentiated, donor1	11276-116H7	25.52	8.72	2.34	1.28	0.00
Osteoblast - differentiated, donor2	11353-117H3	10.29	1.14	3.43	1.14	0.00
Osteoblast - differentiated, donor3	11425-118G3	13.03	8.69	3.10	1.24	0.00
Osteoblast, donor1	11277-116H8	28.34	15.83	4.69	1.76	0.20
Osteoblast, donor2	11354-117H4	37.93	7.73	5.62	2.81	1.40
Osteoblast, donor3	11426-118G4	28.08	5.69	5.33	0.89	0.00
Pancreatic stromal cells, donor1	11249-116E7	25.02	9.94	0.67	0.51	0.00
Pericytes, donor1	11491-119E6	80.78	42.28	6.23	3.34	1.11
Pericytes, donor2	11571-120E5	66.78	42.78	7.47	2.04	0.68
Pericytes, donor3	11652-122E5	25.84	19.94	4.48	1.42	0.20
Perineurial Cells, donor1	11499-119F5	27.35	13.34	3.16	1.36	0.23
Perineurial Cells, donor2	11579-120F4	20.06	7.08	5.24	0.83	0.18
Peripheral Blood Mononuclear Cells, donor1	11231-116C7	150.45	25.82	16.26	5.74	0.32
Peripheral Blood Mononuclear Cells, donor2	11312-117C7	315.38	47.99	60.73	11.75	0.73
Peripheral Blood Mononuclear Cells, donor3	11388-118C2	200.72	45.55	27.44	5.69	0.13
Placental Epithelial Cells, donor1	11278-116H9	137.28	64.57	11.96	2.15	0.72
Placental Epithelial Cells, donor2	11355-117H5	88.71	62.10	8.87	4.44	2.22
Placental Epithelial Cells, donor3	11427-118G5	125.06	100.72	15.90	2.55	0.59
Preadipocyte - breast donor2 (cytoplasmic fraction)	14319-155D8	4.43	0.00	0.95	0.32	0.00
Preadipocyte - breast, donor1	11467-119B9	8.82	1.50	0.56	1.13	0.00
Preadipocyte - breast, donor2 (nuclear fraction)	14320-155D9	16.19	2.09	3.00	0.91	0.13
Preadipocyte - breast, donor2	11328-117E5	6.98	1.35	1.13	0.00	0.23
Preadipocyte - omental, donor1	11468-119C1	10.34	2.66	1.28	0.85	0.00
Preadipocyte - omental, donor2	11329-117E6	2.18	1.31	0.87	0.00	0.00
Preadipocyte - omental, donor3	11403-118D8	18.05	2.29	2.58	0.00	0.00
Preadipocyte - perirenal, donor1	11469-119C2	12.80	0.98	1.97	0.00	0.00
Preadipocyte - subcutaneous, donor1	11279-116I1	50.37	19.35	9.21	1.54	0.61
Preadipocyte - subcutaneous, donor2	11356-117H6	68.35	48.87	11.33	3.54	0.53
Preadipocyte - subcutaneous, donor3	11428-118G6	65.73	21.63	9.71	2.72	0.17
Preadipocyte - visceral, donor1	11280-116I2	81.22	44.43	9.87	3.17	0.56
Preadipocyte - visceral, donor2	11357-117H7	53.38	38.19	16.11	5.52	0.46
Preadipocyte - visceral, donor3	11429-118G7	47.75	23.09	6.48	1.46	0.10
Prostate Epithelial Cells (polarized), donor1	11253-116F2	13.28	8.90	1.06	0.45	0.15
Prostate Epithelial Cells, donor2	11331-117E8	26.27	12.32	2.44	0.95	0.14
Prostate Epithelial Cells, donor3	11404-118D9	12.12	7.47	1.47	0.12	0.00
Prostate Stromal Cells, donor1	11254-116F3	16.29	8.77	0.80	0.23	0.00
Prostate Stromal Cells, donor2	11332-117E9	21.70	12.01	2.69	0.90	0.00
Prostate Stromal Cells, donor3	11405-118E1	21.48	8.97	1.98	1.36	0.00
Renal Cortical Epithelial Cells, donor1	11516-119H4	29.20	8.39	2.55	0.00	0.00
Renal Cortical Epithelial Cells, donor2	11596-120H3	22.25	8.18	1.66	0.62	0.21
Renal Epithelial Cells, donor1	11517-119H5	40.58	21.30	3.04	0.51	0.00
Renal Epithelial Cells, donor2	11597-120H4	27.03	17.78	2.13	0.00	0.00
Renal Epithelial Cells, donor3	11678-122H4	21.17	11.43	2.86	1.27	0.11
Renal Glomerular Endothelial Cells, donor1	11514-119H2	21.79	8.85	0.00	0.00	0.00
Renal Glomerular Endothelial Cells, donor2	11594-120H1	39.62	14.69	4.18	0.94	0.40
Renal Glomerular Endothelial Cells, donor3	11675-122H1	18.20	5.77	2.22	0.89	0.00
Renal Glomerular Endothelial Cells, donor4	11783-124B1	15.31	7.99	0.67	0.00	0.00
Renal Mesangial Cells, donor1	11518-119H6	36.75	14.75	3.74	0.88	0.00
Renal Mesangial Cells, donor2	11598-120H5	23.20	6.27	3.13	1.25	0.00
Renal Mesangial Cells, donor3	11679-122H5	31.35	10.82	4.16	0.83	0.00
Renal Proximal Tubular Epithelial Cell, donor1	11515-119H3	32.21	14.23	2.95	0.54	0.00
Renal Proximal Tubular Epithelial Cell, donor2	11595-120H2	27.41	8.43	3.80	0.00	0.00
Renal Proximal Tubular Epithelial Cell, donor3	11676-122H2	29.89	22.18	2.89	0.77	0.00
Retinal Pigment Epithelial Cells, donor0	11215-116A9	16.59	4.41	1.56	0.52	0.00
Retinal Pigment Epithelial Cells, donor1	11528-119I7	12.51	3.41	1.42	0.00	0.00
Retinal Pigment Epithelial Cells, donor2	11608-120I6	16.47	5.15	0.00	0.00	0.00
Retinal Pigment Epithelial Cells, donor3	11689-122I6	17.06	5.02	0.75	2.01	0.25
SABiosciences XpressRef Human Universal Total RNA, pool1	10002-101A5	79.25	16.70	12.43	2.27	0.67
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep1 (B1 T17)	12697-135D6	2.68	0.00	0.00	0.00	0.00
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep2 (B2 T17)	12795-136F5	6.05	0.55	0.55	0.00	0.00
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep3 (B3 T17)	12893-137H4	6.38	1.74	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep1 (A1 T0)	12662-134I7	6.63	2.08	1.30	0.65	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep2 (A2 T0)	12760-136B6	8.84	2.09	0.99	0.20	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep3 (A3 T0)	12858-137D5	6.69	1.34	0.45	0.11	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep1 (A1 T1)	12663-134I8	16.37	3.72	3.47	1.61	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep2 (A2 T1)	12761-136B7	14.57	1.86	1.05	0.93	0.12
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep3 (A3 T1)	12859-137D6	11.79	0.92	0.92	0.92	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep1 (A1 T2)	12664-134I9	16.57	2.33	2.33	0.96	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep2 (A2 T2)	12762-136B8	12.40	1.06	1.06	0.91	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep3 (A3 T2)	12860-137D7	12.01	1.61	1.61	0.54	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep1 (A1 T3)	12665-135A1	17.79	1.43	2.15	1.86	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep2 (A2 T3)	12763-136B9	14.49	2.68	2.25	0.54	0.21
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep3 (A3 T3)	12861-137D8	11.06	1.99	1.55	0.44	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep1 (A1 T4)	12666-135A2	16.25	2.29	1.34	0.57	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep2 (A2 T4)	12764-136C1	13.79	1.02	1.77	1.40	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep3 (A3 T4)	12862-137D9	11.27	1.88	1.13	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep1 (A1 T5)	12667-135A3	9.42	1.59	0.93	0.80	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep2 (A2 T5)	12765-136C2	15.19	1.85	2.04	1.36	0.10
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep3 (A3 T5)	12863-137E1	11.27	2.29	0.95	0.76	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep1 (A1 T6)	12668-135A4	10.79	2.56	1.50	0.11	0.11
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep2 (A2 T6)	12766-136C3	8.41	1.68	1.40	0.56	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep3 (A3 T6)	12864-137E2	6.67	1.88	0.85	0.51	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep1 (A1 T7)	12669-135A5	6.38	1.46	0.55	0.18	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep2 (A2 T7)	12767-136C4	13.61	2.45	1.72	0.37	0.12
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep3 (A3 T7)	12865-137E3	9.40	1.21	1.48	0.54	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep1 (A1 T8)	12670-135A6	12.03	4.48	0.47	0.47	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep2 (A2 T8)	12768-136C5	10.52	1.98	1.39	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep3 (A3 T8)	12866-137E4	7.48	1.17	0.23	0.94	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep1 (A1 T9)	12671-135A7	16.17	2.28	1.87	1.04	0.21
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep2 (A2 T9)	12769-136C6	7.30	1.33	0.66	0.44	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep3 (A3 T9)	12867-137E5	6.06	1.67	0.63	0.42	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep1 (A1 T10)	12672-135A8	13.86	4.04	1.88	0.81	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep2 (A2 T10)	12770-136C7	9.71	1.02	0.85	0.85	0.17
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep3 (A3 T10)	12868-137E6	9.06	2.51	0.77	0.58	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep1 (A1 T11)	12673-135A9	19.43	4.99	3.27	0.52	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep2 (A2 T11)	12771-136C8	8.92	2.33	1.23	0.41	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep3 (A3 T11)	12869-137E7	6.90	1.48	0.33	1.31	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep1 (A1 T12)	12674-135B1	8.18	1.70	0.68	0.17	0.17
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep2 (A2 T12)	12772-136C9	14.20	1.48	1.63	0.44	0.15
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep3 (A3 T12)	12870-137E8	8.26	2.13	2.13	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep1 (A1 T13)	12675-135B2	2.63	0.83	0.28	0.14	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep2 (A2 T13)	12773-136D1	4.76	0.48	0.48	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep3 (A3 T13)	12871-137E9	8.46	0.81	1.01	0.40	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep1 (A1 T14)	12676-135B3	3.77	0.57	0.47	0.28	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep2 (A2 T14)	12774-136D2	4.89	0.70	0.00	0.70	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep3 (A3 T14)	12872-137F1	4.84	0.60	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep1 (A1 T15)	12677-135B4	6.98	0.86	0.49	0.24	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep2 (A2 T15)	12775-136D3	7.42	0.58	0.87	0.00	0.15
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep3 (A3 T15)	12873-137F2	8.52	1.22	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep1 (A1 T16)	12678-135B5	6.93	1.21	0.60	0.60	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep2 (A2 T16)	12776-136D4	9.05	1.58	0.45	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep3 (A3 T16)	12874-137F3	10.78	2.10	0.60	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep1 (A1 T17)	12679-135B6	7.67	0.71	1.65	0.35	0.12
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep2 (A2 T17)	12777-136D5	9.39	0.85	0.21	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep3 (A3 T17)	12875-137F4	7.81	1.80	0.00	0.00	0.00
Schwann Cells, donor1	11498-119F4	20.88	10.53	2.26	0.38	0.00
Schwann Cells, donor2	11578-120F3	20.41	10.21	6.80	0.00	0.00
Schwann Cells, donor3	11659-122F3	29.58	13.14	2.85	1.10	0.00
Sebocyte, donor1	11220-116B5	56.97	29.03	10.96	1.10	0.55
Sebocyte, donor2	11301-117B5	25.74	15.62	4.14	0.92	0.00
Sebocyte, donor3	11378-118B1	36.48	20.20	2.68	0.00	0.00
Sertoli Cells, donor1	11255-116F4	36.45	6.63	3.31	1.66	0.00
Sertoli Cells, donor2	11333-117F1	16.95	11.30	2.82	0.00	0.00
Skeletal Muscle Cells, donor1	11281-116I3	37.30	25.07	2.73	1.06	0.26
Skeletal Muscle Cells, donor2	11358-117H8	6.51	1.45	1.45	0.00	0.00
Skeletal Muscle Cells, donor3	11430-118G8	43.47	27.59	7.52	1.67	0.00
Skeletal Muscle Cells, donor4	11451-119A2	24.51	13.51	4.87	1.26	0.00
Skeletal Muscle Cells, donor5	11455-119A6	17.54	13.38	2.82	0.45	0.15
Skeletal Muscle Cells, donor6	11459-119B1	25.24	12.00	5.23	0.62	0.00
Skeletal Muscle Satellite Cells, donor1	11240-116D7	10.33	7.69	0.88	0.76	0.00
Skeletal Muscle Satellite Cells, donor2	11321-117D7	15.70	11.56	0.57	0.29	0.14
Skeletal Muscle Satellite Cells, donor3	11397-118D2	36.51	21.13	5.16	0.69	0.00
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor1	11282-116I4	31.76	15.33	2.36	2.11	0.08
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor2	11359-117H9	35.46	14.48	2.90	1.45	0.00
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor3	11431-118G9	42.79	15.00	6.60	1.79	0.14
Skin - palm, donor1	10286-104F7	24.17	5.37	0.00	0.00	0.00
Small Airway Epithelial Cells donor2 (cytoplasmic fraction)	14334-155F5	54.06	20.18	4.47	0.43	0.14
Small Airway Epithelial Cells donor2 (nuclear fraction)	14335-155F6	243.73	49.07	22.08	3.27	0.00
Small Airway Epithelial Cells donor3 (cytoplasmic fraction)	14316-155D5	40.77	12.46	1.95	0.26	0.00
Small Airway Epithelial Cells, donor1	11256-116F5	25.44	13.90	1.67	0.97	0.28
Small Airway Epithelial Cells, donor2	11334-117F2	23.35	16.88	3.24	0.70	0.14
Small Airway Epithelial Cells, donor3 (nuclear fraction)	14317-155D6	180.15	59.42	51.59	2.96	0.42
Small Airway Epithelial Cells, donor3	11406-118E2	17.61	7.57	2.70	0.37	0.07
Smooth Muscle Cells - Aortic, donor0 (cytoplasmic fraction)	14313-155D2	26.54	8.02	5.86	1.23	0.31
Smooth Muscle Cells - Aortic, donor0 (nuclear fraction)	14314-155D3	53.14	9.34	12.45	5.11	1.11
Smooth Muscle Cells - Aortic, donor0	11210-116A4	47.61	19.99	9.41	1.18	1.18
Smooth Muscle Cells - Aortic, donor1	11283-116I5	42.43	22.10	7.73	2.87	0.66
Smooth Muscle Cells - Aortic, donor2	11360-117I1	37.41	13.78	8.66	0.79	0.39
Smooth Muscle Cells - Aortic, donor3	11432-118H1	48.67	12.36	10.04	4.64	3.86
Smooth Muscle Cells - Bladder, donor1	11519-119H7	30.02	20.02	6.00	3.00	0.00
Smooth Muscle Cells - Brachiocephalic, donor1	11284-116I6	34.07	9.05	2.66	1.33	0.40
Smooth Muscle Cells - Brachiocephalic, donor2	11361-117I2	28.59	9.53	7.31	0.89	0.22
Smooth Muscle Cells - Brachiocephalic, donor3	11433-118H2	14.34	6.79	3.20	0.77	0.64
Smooth Muscle Cells - Brain Vascular, donor1	11234-116D1	11.40	5.21	1.95	1.30	0.00
Smooth Muscle Cells - Brain Vascular, donor2	11315-117D1	24.22	7.09	3.84	2.36	0.00
Smooth Muscle Cells - Brain Vascular, donor3	11391-118C5	17.23	5.98	3.13	1.28	0.00
Smooth Muscle Cells - Bronchial, donor1	11512-119G9	30.58	15.78	3.09	1.30	0.16
Smooth Muscle Cells - Bronchial, donor2	11592-120G8	37.75	19.18	7.00	2.13	0.30
Smooth Muscle Cells - Carotid, donor1	11285-116I7	46.47	25.51	6.57	2.78	0.25
Smooth Muscle Cells - Carotid, donor2	11362-117I3	36.72	12.24	12.24	0.00	0.00
Smooth Muscle Cells - Carotid, donor3	11434-118H3	13.83	10.97	3.34	0.48	0.48
Smooth Muscle Cells - Colonic, donor1	11239-116D6	12.09	5.60	1.33	0.29	0.15
Smooth Muscle Cells - Colonic, donor2	11320-117D6	8.39	5.81	1.29	0.22	0.00
Smooth Muscle Cells - Colonic, donor3	11396-118D1	13.96	4.72	2.41	0.21	0.00
Smooth Muscle Cells - Coronary Artery, donor1	11286-116I8	32.64	12.37	5.72	2.17	0.93
Smooth Muscle Cells - Coronary Artery, donor2	11363-117I4	15.09	4.31	1.08	1.08	0.00
Smooth Muscle Cells - Coronary Artery, donor3	11435-118H4	28.69	14.05	5.08	1.49	0.30
Smooth Muscle Cells - Esophageal, donor1	11508-119G5	19.12	19.80	2.73	0.34	0.00
Smooth Muscle Cells - Esophageal, donor2	11588-120G4	25.21	15.08	2.04	0.63	0.16
Smooth Muscle Cells - Internal Thoracic Artery, donor1	11287-116I9	60.49	11.88	13.69	3.62	0.60
Smooth Muscle Cells - Internal Thoracic Artery, donor2	11364-117I5	37.09	24.80	4.78	2.96	0.23
Smooth Muscle Cells - Internal Thoracic Artery, donor3	11436-118H5	39.25	10.26	7.85	1.21	0.00
Smooth Muscle Cells - Intestinal, donor1	11509-119G6	17.22	16.43	2.12	0.26	0.00
Smooth Muscle Cells - Prostate, donor1	11257-116F6	7.59	4.53	0.67	0.27	0.00
Smooth Muscle Cells - Prostate, donor2	11335-117F3	10.14	7.26	1.75	0.13	0.00
Smooth Muscle Cells - Prostate, donor3	11465-119B7	6.09	3.80	0.51	0.25	0.00
Smooth Muscle Cells - Pulmonary Artery, donor1	11288-117A1	50.21	16.59	6.48	2.41	0.45
Smooth Muscle Cells - Pulmonary Artery, donor2	11365-117I6	23.26	11.25	4.50	2.25	0.00
Smooth Muscle Cells - Pulmonary Artery, donor3	11437-118H6	24.55	14.21	6.46	1.29	0.00
Smooth Muscle Cells - Subclavian Artery, donor1	11289-117A2	22.79	11.16	0.93	0.93	0.00
Smooth Muscle Cells - Subclavian Artery, donor2	11366-117I7	33.32	11.61	5.05	1.51	0.00
Smooth Muscle Cells - Subclavian Artery, donor3	11438-118H7	32.59	8.78	7.21	2.19	0.31
Smooth Muscle Cells - Tracheal, donor1	11513-119H1	22.71	8.85	1.77	0.59	0.00
Smooth Muscle Cells - Tracheal, donor2	11593-120G9	23.58	13.33	2.67	1.25	0.25
Smooth Muscle Cells - Tracheal, donor3	11674-122G9	78.95	11.21	12.61	3.27	0.00
Smooth Muscle Cells - Umbilical Artery, donor1	11290-117A3	22.60	5.04	3.17	0.86	0.29
Smooth Muscle Cells - Umbilical Artery, donor2	11367-117I8	39.26	9.69	5.86	2.55	0.00
Smooth Muscle Cells - Umbilical Artery, donor3	11439-118H8	17.49	6.58	2.44	0.56	0.19
Smooth Muscle Cells - Umbilical Vein, donor1	11541-120B2	41.78	6.57	14.81	2.93	0.00
Smooth Muscle Cells - Umbilical Vein, donor2	11621-122B1	17.43	4.78	3.35	0.84	0.08
Smooth Muscle Cells - Umbilical Vein, donor3	11702-123B1	11.90	2.86	0.95	0.00	0.00
Smooth Muscle Cells - Umbilical artery, donor0	11212-116A6	26.18	3.67	3.18	0.98	0.24
Smooth Muscle Cells - Uterine, donor1	11258-116F7	20.33	10.16	5.52	1.77	0.66
Smooth Muscle Cells - Uterine, donor3	11466-119B8	16.68	6.73	2.93	0.88	0.00
Smooth muscle cells - airway, asthmatic, donor1	11960-126C7	103.01	14.38	10.88	2.92	1.55
Smooth muscle cells - airway, asthmatic, donor2	11961-126C8	25.65	3.70	1.59	1.59	0.53
Smooth muscle cells - airway, asthmatic, donor3	11962-126C9	104.15	24.92	7.81	4.09	0.37
Smooth muscle cells - airway, asthmatic, donor4	11963-126D1	43.84	17.25	3.23	1.80	0.36
Smooth muscle cells - airway, asthmatic, donor5	11964-126D2	32.65	4.54	1.14	1.70	0.28
Smooth muscle cells - airway, asthmatic, donor6	11965-126D3	46.87	13.00	3.15	3.94	0.00
Smooth muscle cells - airway, control, donor1	11966-126D4	53.58	12.44	5.33	2.79	0.76
Smooth muscle cells - airway, control, donor2	11967-126D5	96.64	14.77	9.58	3.99	1.60
Smooth muscle cells - airway, control, donor3	11968-126D6	92.38	21.74	7.94	3.34	1.67
Smooth muscle cells - airway, control, donor4	11969-126D7	58.67	11.00	8.25	2.75	0.92
Synoviocyte, donor1	11291-117A4	23.90	5.39	2.36	0.34	0.17
Synoviocyte, donor2	11368-117I9	71.74	8.38	20.62	1.51	0.34
Synoviocyte, donor3	11440-118H9	19.21	5.81	2.46	0.45	0.00
Trabecular Meshwork Cells, donor1	11532-120A2	39.66	25.73	2.86	1.43	0.36
Trabecular Meshwork Cells, donor2	11612-122A1	5.95	7.93	0.00	0.00	0.00
Trabecular Meshwork Cells, donor3	11693-123A1	29.17	20.61	2.08	0.69	0.00
Tracheal Epithelial Cells, donor1	11292-117A5	21.29	11.40	2.01	0.29	0.14
Tracheal Epithelial Cells, donor2	11369-118A1	28.99	12.76	3.09	1.16	0.00
Tracheal Epithelial Cells, donor3	11441-118I1	19.47	9.16	5.15	0.00	0.00
Universal RNA - Human Normal Tissues Biochain, pool1	10007-101B4	85.99	16.49	13.41	1.85	0.86
Urethra, donor2	10319-105A4	26.98	17.98	3.60	0.00	0.00
Urothelial Cells, donor1	11520-119H8	60.57	21.25	6.38	0.80	0.27
Urothelial Cells, donor2	11600-120H7	40.06	15.22	4.01	0.80	0.00
Urothelial Cells, donor3	11681-122H7	54.32	22.92	5.73	1.38	0.00
Urothelial cells, donor0	11216-116B1	97.18	30.98	6.46	2.45	0.22
Whole blood (ribopure), donor090309, donation1	12179-129A1	6.23	5.34	1.78	0.00	0.00
Whole blood (ribopure), donor090309, donation2	12180-129A2	1.43	5.72	0.00	0.00	0.00
Whole blood (ribopure), donor090309, donation3	12181-129A3	3.42	0.68	0.00	0.68	0.00
Whole blood (ribopure), donor090325, donation1	12176-128I7	2.75	2.07	0.00	0.00	0.00
Whole blood (ribopure), donor090325, donation2	12177-128I8	7.55	4.65	0.00	0.58	0.00
Whole blood (ribopure), donor090612, donation1	12182-129A4	5.21	4.16	2.08	2.08	0.00
Whole blood (ribopure), donor090612, donation2	12183-129A5	11.01	5.51	0.00	0.00	0.00
Whole blood (ribopure), donor090612, donation3	12184-129A6	6.39	0.91	0.00	0.00	0.00
Wilms' tumor cell line:G-401	10809-111A8	6.04	0.62	0.49	0.49	0.00
Wilms' tumor cell line:HFWT	10597-108E3	4.40	1.76	0.88	1.76	0.00
acantholytic squamous carcinoma cell line:HCC1806	10717-109I6	25.98	8.94	5.31	3.63	0.84
achilles tendon, donor2	10292-104G4	53.73	12.40	8.27	0.00	0.00
acute lymphoblastic leukemia (B-ALL) cell line:BALL-1	10455-106G5	34.42	1.78	4.08	8.41	0.25
acute lymphoblastic leukemia (B-ALL) cell line:NALM-6	10534-107G3	21.82	0.46	1.86	9.52	0.46
acute lymphoblastic leukemia (T-ALL) cell line:HPB-ALL	10429-106D6	97.70	13.89	16.50	19.71	2.61
acute lymphoblastic leukemia (T-ALL) cell line:Jurkat	10464-106H5	26.12	1.36	3.27	5.99	0.00
acute myeloid leukemia (FAB M0) cell line:KG-1	10827-111C8	0.28	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M0) cell line:Kasumi-3	10789-110H6	13.32	2.54	1.48	0.42	0.21
acute myeloid leukemia (FAB M1) cell line:HYT-1	10828-111C9	13.07	1.63	0.82	0.82	0.00
acute myeloid leukemia (FAB M2) cell line:Kasumi-1	10788-110H5	40.10	3.97	3.08	1.32	0.00
acute myeloid leukemia (FAB M2) cell line:Kasumi-6	10792-110H9	6.13	1.23	1.23	0.00	0.00
acute myeloid leukemia (FAB M2) cell line:NKM-1	10765-110E9	6.99	0.39	0.39	0.78	0.00
acute myeloid leukemia (FAB M3) cell line:HL60	10829-111D1	0.55	0.55	0.18	0.00	0.00
acute myeloid leukemia (FAB M4) cell line:FKH-1	10830-111D2	3.90	0.00	0.00	0.00	3.90
acute myeloid leukemia (FAB M4) cell line:HNT-34	10831-111D3	17.89	1.63	1.39	2.79	0.93
acute myeloid leukemia (FAB M4eo) cell line:EoL-1	10832-111D4	5.95	0.52	0.78	0.26	0.00
acute myeloid leukemia (FAB M4eo) cell line:EoL-3	10833-111D5	0.29	0.29	0.00	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:NOMO-1	10764-110E8	6.51	0.00	0.00	1.86	0.00
acute myeloid leukemia (FAB M5) cell line:P31/FUJ	10770-110F5	16.45	2.06	1.65	8.64	0.41
acute myeloid leukemia (FAB M5) cell line:THP-1 (cytoplasmic fraction)	14298-155B5	1.23	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (fresh)	10399-106A3	7.25	1.28	0.43	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (revived)	10400-106A4	2.73	0.00	0.91	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (thawed)	10405-106A9	87.86	1.93	14.44	4.81	0.72
acute myeloid leukemia (FAB M5) cell line:U-937 DE-4	10834-111D6	1.11	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M6) cell line:EEB	10835-111D7	11.67	3.34	0.67	0.67	0.00
acute myeloid leukemia (FAB M6) cell line:F-36E	10836-111D8	0.00	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M6) cell line:F-36P	10837-111D9	15.07	0.75	1.13	1.51	0.00
acute myeloid leukemia (FAB M7) cell line:M-MOK	10699-109G6	0.00	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M7) cell line:MKPL-1	10802-111A1	3.75	0.00	0.00	0.00	1.87
adenocarcinoma cell line:IM95m	10796-110I4	27.08	1.18	6.36	2.12	0.47
adipose tissue, adult, pool1	10010-101C1	86.56	23.11	7.45	2.48	0.31
adipose, donor1	10184-103D4	5.86	3.52	0.00	0.59	0.00
adipose, donor2	10185-103D5	14.19	6.08	1.22	1.22	0.00
adipose, donor3	10186-103D6	22.06	8.71	2.45	0.00	0.27
adipose, donor4	10187-103D7	30.34	10.40	1.73	2.60	0.00
adrenal cortex adenocarcinoma cell line:SW-13	10810-111A9	2.68	0.47	0.47	0.16	0.16
adrenal gland, adult, pool1	10081-102A9	32.74	0.00	3.64	0.00	0.00
adult T-cell leukemia cell line:ATN-1	10421-106C7	9.34	2.80	0.53	0.67	0.27
alveolar cell carcinoma cell line:SW 1573	10708-109H6	86.11	21.44	13.58	15.36	2.50
amniotic membrane cells, donor1	12235-129G3	213.53	62.37	28.98	3.01	0.00
amniotic membrane cells, donor2	12236-129G4	61.20	35.16	6.42	1.35	0.00
amniotic membrane cells, donor3	12237-129G5	211.82	65.11	25.63	2.36	0.88
amygdala - adult, donor10196	10167-103B5	87.75	28.46	4.74	2.37	1.19
amygdala, adult, donor10252	10151-102I7	76.85	28.18	5.27	0.41	0.20
amygdala, newborn, donor10223	10360-105E9	48.42	15.49	3.55	1.94	0.00
anaplastic carcinoma cell line:8305C	10428-106D5	64.43	15.41	6.88	12.10	4.33
anaplastic large cell lymphoma cell line:Ki-JK	10795-110I3	26.70	12.80	1.54	2.43	0.00
anaplastic squamous cell carcinoma cell line:RPMI 2650	10805-111A4	12.03	1.34	1.67	1.34	0.00
aorta, adult, pool1	10052-101G7	155.14	14.12	28.05	3.33	0.39
appendix, adult	10189-103D9	102.46	12.03	20.96	1.94	0.78
argyrophil small cell carcinoma cell line:TC-YIK	10589-108D4	38.18	11.35	9.29	11.69	1.72
artery, adult	10190-103E1	80.16	8.15	9.51	2.72	0.00
astrocytoma cell line:TM-31	10425-106D2	99.52	24.77	19.27	12.46	1.45
b cell line:RPMI1788	10427-106D4	29.44	3.12	2.08	0.89	0.15
basal cell carcinoma cell line:TE 354.T	10702-109G9	32.46	1.94	7.77	2.22	0.55
bile duct carcinoma cell line:HuCCT1	10432-106D9	27.69	5.76	3.37	3.67	2.08
bile duct carcinoma cell line:TFK-1	10496-107C1	58.75	8.37	4.18	2.18	0.33
biphenotypic B myelomonocytic leukemia cell line:MV-4-11	10718-109I7	12.86	1.12	2.80	0.00	0.00
bladder, adult, pool1	10011-101C2	91.69	19.45	8.04	1.74	0.11
blood, adult, pool1	10053-101G8	17.72	4.43	0.00	0.00	0.00
bone marrow stromal cell line:StromaNKtert	10686-109F2	5.99	0.86	2.57	0.86	1.71
bone marrow, adult	10192-103E3	57.36	13.50	3.37	4.72	0.00
brain, adult, donor1	10084-102B3	20.50	5.13	1.03	0.00	0.00
brain, adult, pool1	10012-101C3	40.53	11.47	3.67	0.78	0.00
brain, fetal, pool1	10085-102B4	58.77	16.03	2.67	2.67	0.00
breast carcinoma cell line:MCF7	10482-107A5	90.85	42.29	12.22	6.61	1.98
breast carcinoma cell line:MDA-MB-453	10419-106C5	172.13	38.32	31.83	8.49	3.62
breast, adult, donor1	10080-102A8	66.92	18.94	6.94	1.89	1.89
bronchial squamous cell carcinoma cell line:KNS-62	10760-110E4	6.10	2.16	1.14	0.13	0.00
bronchioalveolar carcinoma cell line:NCI-H358	10709-109H7	80.40	25.36	20.10	4.33	0.31
bronchioalveolar carcinoma cell line:NCI-H650	10715-109I4	28.55	6.68	5.06	11.05	1.38
bronchogenic carcinoma cell line:ChaGo-K-1	10710-109H8	23.97	3.63	3.39	2.18	0.00
carcinoid cell line:NCI-H1770	10703-109H1	42.79	5.64	6.58	6.11	0.47
carcinoid cell line:NCI-H727	10735-110B6	13.34	1.42	1.53	0.88	0.00
carcinoid cell line:SK-PN-DW	10719-109I8	32.96	6.97	8.24	4.75	0.63
carcinosarcoma cell line:JHUCS-1	10642-109A3	10.38	1.86	0.80	1.60	0.00
caudate nucleus - adult, donor10196	10177-103C6	86.35	23.03	6.91	0.00	0.00
caudate nucleus, adult, donor10252	10164-103B2	29.62	19.24	2.18	0.50	0.00
caudate nucleus, adult, donor10258	10379-105H1	11.46	6.88	0.76	0.00	0.00
caudate nucleus, newborn, donor10223	10354-105E3	57.86	35.16	4.39	0.00	0.37
cerebellum - adult, donor10196	10173-103C2	61.18	23.31	5.83	2.91	0.00
cerebellum, adult, donor10252	10166-103B4	80.71	25.19	1.49	1.92	0.00
cerebellum, adult, pool1	10083-102B2	27.25	7.24	1.72	0.34	0.00
cerebellum, newborn, donor10223	10357-105E6	39.02	10.79	0.83	0.83	0.00
cerebral meninges, adult	10188-103D8	74.89	10.09	8.82	3.03	0.25
cerebrospinal fluid, donor2	10294-104G6	7.31	1.46	2.92	0.73	0.00
cervical cancer cell line:D98-AH2	10552-107I3	44.72	3.88	8.20	2.88	1.01
cervical cancer cell line:ME-180	10553-107I4	77.06	3.81	20.55	3.15	0.50
cervix, adult, pool1	10013-101C4	159.17	30.55	34.86	3.67	2.31
cholangiocellular carcinoma cell line:HuH-28	10536-107G5	46.68	14.91	9.20	6.55	1.67
chondrosarcoma cell line:SW 1353	10700-109G7	18.29	0.00	1.31	2.61	0.00
choriocarcinoma cell line:BeWo	10423-106C9	0.50	0.00	0.00	0.00	0.00
choriocarcinoma cell line:SCH	10785-110H2	1.60	0.37	0.00	0.25	0.00
choriocarcinoma cell line:T3M-3	10618-108G6	0.95	0.00	0.24	0.00	0.00
chorionic membrane cells, donor1	12238-129G6	360.71	153.57	55.56	1.99	1.42
chorionic membrane cells, donor2	12239-129G7	19.69	11.53	2.39	0.30	0.00
chorionic membrane cells, donor3	12240-129G8	275.29	214.85	55.50	0.55	0.55
chronic lymphocytic leukemia (T-CLL) cell line:SKW-3	10416-106C2	15.15	4.04	3.03	9.09	3.03
chronic myeloblastic leukemia (CML) cell line:KCL-22	10801-110I9	1.34	0.00	0.00	0.00	0.00
chronic myelogenous leukemia (CML) cell line:MEG-A2	10766-110F1	1.69	0.21	0.42	0.21	0.00
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep1	10824-111C5	5.14	1.03	0.26	0.77	0.00
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep2	10825-111C6	3.87	0.48	1.21	0.24	0.00
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep3	10826-111C7	3.66	2.24	0.61	0.00	0.00
chronic myelogenous leukemia cell line:K562	10454-106G4	4.42	1.47	1.47	2.94	0.59
chronic myelogenous leukemia cell line:KU812	10409-106B4	6.78	0.52	0.78	1.82	0.52
clear cell carcinoma cell line:JHOC-5	10638-108I8	39.77	8.91	7.77	12.57	2.29
clear cell carcinoma cell line:TEN	10636-108I6	55.70	8.85	6.94	2.26	1.21
colon carcinoma cell line:CACO-2	10513-107D9	32.58	13.55	5.49	3.66	0.55
colon carcinoma cell line:COLO-320	10420-106C6	52.45	10.26	6.46	4.18	0.76
colon, adult, donor1	10082-102B1	33.32	3.57	4.76	1.19	0.00
colon, adult, pool1	10014-101C5	75.79	29.73	8.81	1.76	0.59
colon, fetal, donor1	10070-101I7	181.07	44.50	23.48	4.33	2.47
common myeloid progenitor CMP, donor1	12130-128D6	132.92	4.58	13.75	13.75	0.00
common myeloid progenitor CMP, donor2	12134-128E1	50.07	25.04	25.04	0.00	0.00
cord blood derived cell line:COBL-a 24h infection(-C)	10452-106G2	147.45	87.11	45.47	13.17	3.40
cord blood derived cell line:COBL-a 24h infection	10453-106G3	37.58	28.98	5.74	2.72	0.30
cord blood derived cell line:COBL-a untreated	10449-106F8	25.24	21.01	4.65	2.12	0.00
corpus callosum, adult, pool1	10042-101F6	99.40	26.20	8.51	1.44	0.44
cruciate ligament, donor2	10295-104G7	30.80	6.48	5.67	0.00	0.81
diaphragm, fetal, donor1	10069-101I6	105.94	11.24	14.45	0.00	0.00
diencephalon, adult	10193-103E4	26.64	8.16	2.40	0.24	0.00
diffuse large B-cell lymphoma cell line:CTB-1	10631-108I1	21.35	1.15	2.53	4.59	0.46
ductal cell carcinoma cell line:KLM-1	10438-106E6	58.47	15.64	6.41	5.64	1.03
ductal cell carcinoma cell line:MIA Paca2	10488-107B2	70.29	14.44	13.48	6.02	1.93
ductus deferens, adult	10196-103E7	78.24	14.45	1.99	1.00	0.00
duodenum, fetal, donor1, tech_rep1	10071-101I8	90.73	31.69	18.72	2.88	0.00
duodenum, fetal, donor1, tech_rep2	10071-101I8	132.42	59.59	13.24	1.47	2.21
dura mater, adult, donor1	10041-101F5	172.03	15.61	39.89	4.21	1.24
embryonic kidney cell line: HEK293/SLAM infection, 24hr	10451-106G1	267.82	104.60	66.84	41.31	6.88
embryonic kidney cell line: HEK293/SLAM untreated	10450-106F9	38.98	21.64	9.74	3.73	0.57
embryonic pancreas cell line:1B2C6	10604-108F1	12.33	3.08	1.23	0.62	0.62
embryonic pancreas cell line:1C3D3	10605-108F2	11.20	2.72	0.91	2.72	0.30
embryonic pancreas cell line:1C3IKEI	10606-108F3	10.19	1.85	1.23	0.93	0.00
embryonic pancreas cell line:2C6	10603-108E9	9.19	2.63	0.00	1.31	0.00
endometrial carcinoma cell line:OMC-2	10497-107C2	13.74	3.02	3.02	2.35	0.34
endometrial stromal sarcoma cell line:OMC-9	10448-106F7	52.38	9.61	6.89	5.07	2.17
endometrioid adenocarcinoma cell line:JHUEM-1	10643-109A4	32.00	10.29	6.27	0.96	0.00
epidermoid carcinoma cell line:A431	10426-106D3	91.04	12.89	18.90	9.00	3.00
epidermoid carcinoma cell line:Ca Ski	10431-106D8	136.38	26.51	23.43	10.01	3.63
epididymis, adult	10197-103E8	51.91	13.81	5.86	0.84	0.63
epithelioid sarcoma cell line:HS-ES-1	10443-106F2	86.75	5.85	22.00	14.73	1.95
epithelioid sarcoma cell line:HS-ES-2R	10495-107B9	5.11	0.79	1.57	1.97	0.00
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep1	10815-111B5	4.32	0.52	0.13	0.00	0.00
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep2	10816-111B6	10.24	2.17	0.30	0.00	0.00
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep3	10817-111B7	3.58	0.56	0.00	0.00	0.11
esophagus, adult, pool1	10015-101C6	70.29	19.54	6.16	1.70	0.21
extraskeletal myxoid chondrosarcoma cell line:H-EMC-SS	10410-106B5	24.17	6.76	1.75	1.63	0.25
eye - muscle inferior rectus, donor1	10272-104E2	24.15	14.49	0.00	0.00	0.00
eye - muscle lateral, donor2	10298-104H1	14.73	2.10	0.00	0.00	0.00
eye - muscle medial, donor2	10299-104H2	17.86	1.49	0.00	0.00	0.00
eye - muscle superior, donor2	10297-104G9	21.78	6.88	3.44	0.00	0.00
eye - vitreous humor, donor1	10268-104D7	23.32	5.83	0.00	0.00	0.00
eye, fetal, donor1	10054-101G9	141.35	28.98	12.97	3.05	1.78
fibrosarcoma cell line:HT-1080	10758-110E2	26.16	7.05	3.21	2.56	0.38
fibrous histiocytoma cell line:GCT TIB-223	10711-109H9	28.73	9.02	5.22	9.97	2.14
frontal lobe, adult, pool1	10040-101F4	47.85	8.26	4.32	2.25	0.19
gall bladder carcinoma cell line:TGBC14TKB	10470-106I2	104.79	23.12	31.23	12.31	2.40
gall bladder carcinoma cell line:TGBC2TKB	10415-106C1	41.42	7.22	5.30	6.40	1.46
gall bladder, adult	10198-103E9	102.13	11.11	28.73	7.48	2.90
gamma delta positive T cells, donor1	11937-126A2	10.74	2.68	1.07	1.07	0.54
gamma delta positive T cells, donor2	11938-126A3	9.71	3.36	0.75	0.37	0.37
gastric adenocarcinoma cell line:MKN1	10614-108G2	27.88	8.24	4.44	7.18	0.21
gastric adenocarcinoma cell line:MKN45	10612-108F9	73.88	8.90	18.95	10.44	2.32
gastric cancer cell line:AZ521	10549-107H9	4.26	1.48	1.31	1.15	0.33
gastric cancer cell line:GSS	10560-108A2	22.88	1.83	3.66	5.49	0.00
gastrointestinal carcinoma cell line:ECC12	10615-108G3	49.80	6.17	16.68	13.48	2.97
giant cell carcinoma cell line:LU65	10487-107B1	23.18	4.02	1.61	2.87	0.34
giant cell carcinoma cell line:Lu99B	10433-106E1	203.08	13.16	45.49	14.42	8.26
glassy cell carcinoma cell line:HOKUG	10688-109F4	47.39	5.49	8.73	3.74	1.75
glioblastoma cell line:A172, tech_rep1	10444-106F3	17.31	3.27	2.01	2.22	0.32
glioblastoma cell line:A172, tech_rep2	10444-106F3	16.15	4.07	1.69	1.97	1.12
glioblastoma cell line:T98G	10485-107A8	93.49	14.46	17.11	19.98	6.95
glioma cell line:GI-1	10413-106B8	70.29	9.96	9.96	16.40	3.81
globus pallidus - adult, donor10196	10175-103C4	56.13	11.66	2.92	0.73	0.00
globus pallidus, adult, donor10252	10161-103A8	36.86	17.57	2.20	0.24	0.24
globus pallidus, adult, donor10258	10367-105F7	46.55	12.32	5.48	1.37	0.00
globus pallidus, newborn, donor10223	10364-105F4	51.69	18.12	1.60	1.07	0.00
granulocyte macrophage progenitor, donor1	12131-128D7	68.52	4.89	4.89	4.89	0.00
granulocyte macrophage progenitor, donor2	12135-128E2	43.71	0.00	0.00	0.00	0.00
granulocyte macrophage progenitor, donor3	12139-128E6	10.45	0.00	0.00	0.00	0.00
granulosa cell tumor cell line:KGN	10624-108H3	23.36	6.08	6.72	3.52	1.28
hIPS +CCl2, biol_rep1	14383-156B9	11.02	4.13	0.46	0.46	0.00
hIPS +CCl2, biol_rep2	14384-156C1	10.97	4.57	0.00	0.00	0.00
hIPS +CCl2, biol_rep3	14385-156C2	10.95	2.58	0.00	0.00	0.00
hIPS, biol_rep1	14380-156B6	24.43	2.87	2.87	0.00	0.00
hIPS, biol_rep2	14381-156B7	15.77	5.49	0.00	0.00	0.00
hIPS, biol_rep3	14382-156B8	23.17	12.14	0.00	0.00	0.00
hairy cell leukemia cell line:Mo	10712-109I1	31.32	6.61	3.45	2.59	0.57
heart - mitral valve, adult	10205-103F7	79.82	12.56	12.56	0.90	0.60
heart - pulmonic valve, adult	10206-103F8	46.80	7.06	5.23	1.05	0.00
heart - tricuspid valve, adult	10207-103F9	47.46	15.82	4.16	1.67	0.00
heart, adult, diseased post-infarction, donor1	10050-101G5	25.10	5.92	4.49	0.61	0.61
heart, adult, diseased, donor1	10051-101G6	35.34	3.83	6.39	2.13	0.43
heart, adult, pool1	10016-101C7	28.75	4.14	4.37	0.92	0.46
heart, fetal, pool1	10046-101G1	126.81	11.91	26.29	4.62	0.51
hepatic mesenchymal tumor cell line:LI90	10778-110G4	17.59	3.09	2.78	1.23	0.00
hepatoblastoma cell line:HuH-6	10633-108I3	38.05	23.78	8.32	4.76	5.95
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep1	10818-111B8	13.70	8.40	1.55	0.44	0.00
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep2	10819-111B9	12.26	8.74	2.43	0.49	0.00
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep3	10820-111C1	14.85	10.61	2.22	0.61	0.00
hepatoma cell line:Li-7	10484-107A7	32.92	5.89	4.78	8.34	1.89
hereditary spherocytic anemia cell line:WIL2-NS	10808-111A7	2.41	0.50	0.00	0.20	0.00
hippocampus - adult, donor10196	10169-103B7	46.37	13.25	2.84	1.89	0.00
hippocampus, adult, donor10252	10153-102I9	65.72	24.29	4.69	0.20	0.20
hippocampus, adult, donor10258	10374-105G5	22.91	6.97	1.00	0.50	0.00
hippocampus, newborn, donor10223	10363-105F3	43.71	12.69	1.41	2.11	0.35
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep1	13421-144D1	97.66	18.31	6.71	5.49	0.61
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep2	13425-144D5	37.50	16.10	6.68	2.55	0.59
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep3	13429-144D9	56.62	12.95	5.33	2.03	0.76
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep1	13422-144D2	1.13	0.56	0.00	0.00	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep2	13426-144D6	1.81	1.03	0.26	0.26	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep3	13430-144E1	3.80	0.00	0.00	0.00	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep1	13423-144D3	35.62	11.39	1.46	0.58	0.29
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep2	13427-144D7	24.99	12.71	1.08	0.43	0.43
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep3	13431-144E2	34.20	14.60	2.09	2.09	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep1	13424-144D4	17.76	7.81	0.24	1.18	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep2	13428-144D8	20.57	13.50	3.38	1.29	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep3	13432-144E3	14.14	9.43	1.35	0.67	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep1	13433-144E4	30.05	10.02	2.03	2.50	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep2	13437-144E8	38.81	8.84	5.40	1.47	0.49
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep3	13441-144F3	41.89	9.60	2.62	6.11	0.87
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep1	13434-144E5	2.29	0.95	0.38	0.19	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep2	13438-144E9	2.18	1.31	0.44	0.00	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep3	13442-144F4	2.50	1.00	0.00	0.00	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep1	13435-144E6	13.75	11.30	1.32	1.13	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep2	13439-144F1	10.46	8.64	0.91	1.36	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep3	13443-144F5	16.29	10.96	0.94	0.31	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep1	13436-144E7	11.43	8.82	0.98	0.98	0.16
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep2	13440-144F2	11.03	7.55	2.03	0.00	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep3	13444-144F6	16.44	8.07	0.90	0.60	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep1	13445-144F7	18.47	8.31	2.40	1.66	0.55
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep2	13449-144G2	25.96	8.27	2.28	2.00	0.29
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep3	13453-144G6	46.55	9.80	1.22	2.45	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep1	13446-144F8	2.46	2.82	0.35	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep2	13450-144G3	2.85	1.58	0.00	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep3	13454-144G7	5.14	1.82	0.00	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep1	13447-144F9	15.51	7.76	1.03	0.52	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep2	13451-144G4	13.28	7.31	0.00	0.66	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep3	13455-144G8	15.91	9.49	0.77	0.77	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep1	13448-144G1	18.66	13.29	2.30	0.26	0.26
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep2	13452-144G5	15.14	12.87	0.76	2.27	0.76
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep3	13456-144G9	23.19	10.75	1.68	0.67	0.34
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep1	13457-144H1	18.84	8.69	2.42	1.69	0.72
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep2	13461-144H5	27.63	9.80	0.89	2.23	0.45
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep3	13465-144H9	35.61	7.80	2.93	2.93	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep1	13458-144H2	2.14	0.61	0.00	0.31	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep2	13462-144H6	0.00	3.25	3.25	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep3	13466-144I1	4.30	1.65	0.00	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep1	13459-144H3	15.32	12.59	1.09	2.74	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep2	13463-144H7	23.52	14.48	0.72	1.09	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep3	13467-144I2	19.93	10.32	0.71	1.78	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep1	13460-144H4	14.32	13.13	0.00	1.19	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep2	13464-144H8	26.27	18.69	2.98	1.22	0.14
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep3	13468-144I3	27.48	15.36	2.16	1.08	0.00
immature langerhans cells, donor1	11904-125F5	99.28	16.95	16.47	3.39	1.21
immature langerhans cells, donor2	11905-125F6	335.86	45.94	57.03	11.88	0.79
insula, adult, pool1	10039-101F3	53.28	11.92	2.93	1.51	0.19
keratoacanthoma cell line:HKA-1	10791-110H8	45.85	8.45	8.13	1.30	0.00
kidney, adult, pool1	10017-101C8	27.43	9.31	3.10	0.30	0.00
kidney, fetal, pool1	10045-101F9	101.29	32.11	10.68	1.56	0.35
large cell lung carcinoma cell line:IA-LM	10509-107D5	83.93	6.53	28.12	7.53	1.56
large cell lung carcinoma cell line:NCI-H460	10839-111E2	11.75	1.11	1.80	2.21	0.14
large cell non-keratinizing squamous carcinoma cell line:SKG-II-SF	10692-109F8	123.50	18.35	24.04	9.17	4.22
left atrium, adult, donor1	10079-102A7	33.24	4.90	5.45	1.63	1.63
left ventricle, adult, donor1	10078-102A6	18.20	2.02	5.06	0.51	0.00
leiomyoblastoma cell line:G-402	10721-110A1	58.28	4.38	14.23	6.29	2.19
leiomyoma cell line:10964C	10569-108B2	26.58	9.70	3.95	1.08	1.08
leiomyoma cell line:15242A	10570-108B3	19.02	7.61	1.09	3.26	0.54
leiomyoma cell line:15425	10571-108B4	27.92	9.96	7.28	0.97	0.24
leiomyosarcoma cell line:Hs 5.T	10722-110A2	44.45	0.00	12.70	0.00	0.00
lens epithelial cell line:SRA 01/04	10647-109A8	3.14	1.05	1.05	2.09	0.00
leukemia, chronic megakaryoblastic cell line:MEG-01	10752-110D5	17.35	3.19	3.42	3.90	0.83
liposarcoma cell line:KMLS-1	10782-110G8	39.05	9.53	4.22	4.06	1.72
liposarcoma cell line:SW 872	10726-110A6	23.51	3.78	3.05	1.58	0.61
liver, adult, pool1	10018-101C9	45.05	14.26	5.35	0.81	0.16
liver, fetal, pool1	10086-102B5	54.56	7.53	10.35	0.94	0.94
locus coeruleus - adult, donor10196	10182-103D2	38.64	16.04	4.67	0.87	0.73
locus coeruleus, adult, donor10252	10165-103B3	49.46	19.56	3.69	0.55	0.18
locus coeruleus, adult, donor10258	10375-105G6	31.32	6.77	1.97	0.28	0.56
locus coeruleus, newborn, donor10223	10362-105F2	55.94	28.18	1.26	1.26	0.00
lung adenocarcinoma cell line:A549	10499-107C4	19.24	1.38	3.46	1.52	0.28
lung adenocarcinoma cell line:PC-14	10408-106B3	15.17	7.58	0.69	2.07	0.00
lung adenocarcinoma, papillary cell line:NCI-H441	10742-110C4	22.80	5.40	3.82	1.71	0.40
lung, adult, pool1	10019-101D1	159.35	21.14	23.03	4.49	1.06
lung, fetal, donor1	10068-101I5	339.92	90.19	53.37	6.56	2.28
lung, right lower lobe, adult, donor1	10075-102A3	62.78	12.37	16.50	1.83	0.00
lymph node, adult, donor1	10077-102A5	9.47	2.37	0.95	0.00	0.00
lymphangiectasia cell line:DS-1	10727-110A7	247.45	6.14	14.03	6.14	1.97
lymphoma, malignant, hairy B-cell cell line:MLMA	10775-110G1	6.04	0.30	0.60	1.66	0.15
malignant trichilemmal cyst cell line:DJM-1	10412-106B7	19.54	8.49	5.10	11.04	1.70
mature adipocyte, donor1	12231-129F8	923.94	114.55	160.72	8.88	0.89
mature adipocyte, donor2	12232-129F9	776.36	96.09	131.78	2.91	1.66
mature adipocyte, donor3	12233-129G1	765.00	120.43	83.92	2.61	0.24
mature adipocyte, donor4	12234-129G2	857.83	107.92	118.18	5.53	3.69
maxillary sinus tumor cell line:HSQ-89	10414-106B9	31.45	8.58	7.39	8.82	1.19
medial frontal gyrus - adult, donor10196	10170-103B8	54.15	14.66	1.13	1.13	0.00
medial frontal gyrus, adult, donor10252	10150-102I6	59.03	21.88	3.49	2.57	0.00
medial frontal gyrus, adult, donor10258	10368-105F8	13.66	4.45	1.27	0.32	0.32
medial frontal gyrus, newborn, donor10223	10352-105E1	62.69	20.04	0.85	1.71	0.00
medial temporal gyrus - adult, donor10196	10183-103D3	37.97	14.18	2.36	1.01	0.34
medial temporal gyrus, adult, donor10252	10156-103A3	40.11	14.43	1.91	0.21	0.42
medial temporal gyrus, adult, donor10258, tech_rep1	10376-105G7	50.08	0.00	0.00	0.00	1.93
medial temporal gyrus, adult, donor10258, tech_rep2	10376-105G7	43.06	0.00	0.00	0.00	0.00
medial temporal gyrus, newborn, donor10223	10353-105E2	67.48	15.08	2.51	3.23	1.79
medulla oblongata - adult, donor10196	10174-103C3	57.11	16.22	2.60	0.65	0.65
medulla oblongata, adult, donor10252	10155-103A2	85.61	21.83	5.57	0.46	0.15
medulla oblongata, adult, pool1	10038-101F2	64.40	14.12	7.18	0.41	0.08
medulla oblongata, newborn, donor10223	10361-105F1	38.54	21.87	2.43	1.04	0.69
medulloblastoma cell line:D283 Med	10838-111E1	160.08	21.92	34.98	31.00	4.65
medulloblastoma cell line:ONS-76	10759-110E3	21.89	3.06	3.06	2.20	1.10
melanoma cell line:COLO 679	10514-107E1	9.92	0.43	1.72	2.73	0.86
melanoma cell line:G-361	10465-106H6	11.13	0.00	1.63	1.09	0.00
meningioma cell line:HKBMM	10691-109F7	26.77	7.96	6.15	4.34	1.45
merkel cell carcinoma cell line:MKL-1	10843-111E6	16.74	9.69	0.00	0.00	0.00
merkel cell carcinoma cell line:MS-1	10844-111E7	35.00	14.26	3.63	1.30	0.26
mesenchymal precursor cell - adipose, donor1	11747-123G1	36.67	17.80	8.29	1.84	0.00
mesenchymal precursor cell - adipose, donor2	11748-123G2	52.35	11.27	12.54	1.27	0.55
mesenchymal precursor cell - adipose, donor3	11749-123G3	42.24	27.74	6.21	0.83	0.83
mesenchymal precursor cell - bone marrow, donor1	11750-123G4	49.59	7.30	16.58	1.83	0.28
mesenchymal precursor cell - bone marrow, donor2	11751-123G5	55.65	19.45	15.79	1.35	0.39
mesenchymal precursor cell - bone marrow, donor3	11840-124H4	37.48	13.88	8.33	4.86	0.69
mesenchymal precursor cell - cardiac, donor1	11752-123G6	63.16	12.36	28.83	1.54	0.17
mesenchymal precursor cell - cardiac, donor2	11753-123G7	47.27	12.08	18.98	2.19	0.46
mesenchymal precursor cell - cardiac, donor3	11754-123G8	17.64	5.57	5.70	1.72	0.40
mesenchymal precursor cell - cardiac, donor4	11755-123G9	43.35	12.56	17.96	2.97	0.41
mesenchymal precursor cell - ovarian cancer left ovary, donor1	11756-123H1	43.82	17.78	12.09	2.56	0.57
mesenchymal precursor cell - ovarian cancer left ovary, donor2	11833-124G6	44.46	19.10	5.60	2.63	0.66
mesenchymal precursor cell - ovarian cancer left ovary, donor3	11760-123H5	72.09	27.95	18.27	3.87	0.55
mesenchymal precursor cell - ovarian cancer left ovary, donor4	11836-124G9	30.02	7.68	4.89	1.75	0.35
mesenchymal precursor cell - ovarian cancer metastasis, donor1	11758-123H3	35.93	8.17	9.60	1.63	0.00
mesenchymal precursor cell - ovarian cancer metastasis, donor2	11835-124G8	35.23	6.11	5.39	0.72	0.00
mesenchymal precursor cell - ovarian cancer metastasis, donor3	11762-123H7	66.73	12.00	33.52	2.48	1.03
mesenchymal precursor cell - ovarian cancer metastasis, donor4	11838-124H2	37.85	12.08	9.35	3.65	0.68
mesenchymal precursor cell - ovarian cancer right ovary, donor1	11757-123H2	44.05	10.91	13.01	2.52	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor2	11759-123H4	56.64	13.90	18.68	2.69	0.30
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02)	11761-123H6	21.97	5.86	6.21	0.79	0.09
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02-G)	11842-124H6	60.01	15.09	15.83	4.05	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor4	11837-124H1	34.91	11.45	9.73	1.72	0.29
mesenchymal stem cell line:Hu5/E18	10568-108B1	23.16	4.63	3.37	5.89	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep1	13229-141I7	10.96	7.76	1.37	0.91	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep2	13230-141I8	13.05	3.58	1.28	0.51	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep3	13231-141I9	10.73	2.62	1.57	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep1	13232-142A1	11.09	4.01	0.92	0.92	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep2	13233-142A2	8.24	3.53	1.18	0.24	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep3	13234-142A3	9.14	3.38	1.69	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep1	13235-142A4	12.18	5.50	0.00	0.79	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep2	13236-142A5	11.58	3.24	0.46	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep3	13237-142A6	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep1	13238-142A7	12.40	4.61	1.44	0.87	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep2	13239-142A8	11.38	4.69	1.34	0.45	0.22
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep3	13240-142A9	12.98	5.53	0.24	0.72	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep1	13241-142B1	5.13	2.20	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep2	13242-142B2	9.40	4.03	0.67	0.34	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep3	13243-142B3	11.87	3.68	0.41	0.41	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep1	13244-142B4	10.74	7.30	1.29	0.86	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep2	13245-142B5	8.20	10.94	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep3	13246-142B6	25.82	5.16	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep1	13247-142B7	13.32	7.79	1.62	0.32	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep2	13248-142B8	16.00	7.27	0.00	2.91	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep3	13249-142B9	18.12	8.53	1.07	1.60	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep1	13250-142C1	13.90	2.45	0.00	0.82	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep2	13251-142C2	15.94	6.61	0.78	0.39	0.78
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep3	13252-142C3	14.69	4.20	2.10	4.20	2.10
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep1	13253-142C4	15.90	1.99	2.98	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep2	13254-142C5	4.77	14.30	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep3	13255-142C6	13.05	12.45	0.59	1.78	0.59
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep1	13256-142C7	18.28	8.53	1.22	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep2	13257-142C8	27.05	54.10	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep3	13258-142C9	16.47	8.87	1.27	0.00	0.63
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep1	13259-142D1	17.59	8.62	1.72	0.34	0.34
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep2	13260-142D2	25.79	12.90	0.00	2.15	2.15
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep3	13261-142D3	11.98	7.98	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep1	13262-142D4	0.00	10.33	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep2	13263-142D5	24.04	13.85	0.81	0.81	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep3	13264-142D6	20.66	10.33	0.79	0.79	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep1	13265-142D7	22.40	11.79	2.95	0.00	0.59
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep2	13266-142D8	22.75	16.83	1.25	0.62	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep3	13267-142D9	17.38	17.38	0.00	4.01	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep1	13268-142E1	9.46	2.37	1.18	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep2	13269-142E2	15.41	7.70	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep3	13270-142E3	22.03	10.33	0.69	0.69	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep1	13271-142E4	4.95	1.48	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep2	13272-142E5	10.09	1.12	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep3	13273-142E6	3.18	2.54	1.27	0.64	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep1	13274-142E7	13.30	1.61	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep2	13275-142E8	0.00	8.72	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep3	13276-142E9	11.40	3.80	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep1	13277-142F1	13.35	2.43	0.61	0.61	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep2	13278-142F2	18.08	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep3	13279-142F3	18.12	1.65	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep1	13280-142F4	4.37	3.97	0.40	0.20	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep2	13281-142F5	6.17	3.24	0.32	0.32	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep3	13282-142F6	14.26	0.00	0.00	0.00	0.00
mesodermal tumor cell line:HIRS-BM	10696-109G3	22.44	6.19	3.09	2.32	0.77
mesothelioma cell line:ACC-MESO-1	10493-107B7	47.01	8.98	7.09	4.96	1.89
mesothelioma cell line:ACC-MESO-4	10494-107B8	11.35	4.63	2.55	3.94	0.46
mesothelioma cell line:Mero-14, tech_rep1	10849-111F3	12.82	12.82	0.00	0.00	0.00
mesothelioma cell line:Mero-14, tech_rep2	10849-111F3	11.10	6.27	1.23	1.34	0.00
mesothelioma cell line:Mero-25	10850-111F4	15.66	1.82	1.59	1.59	0.00
mesothelioma cell line:Mero-41	10851-111F5	29.09	22.74	4.65	0.24	0.00
mesothelioma cell line:Mero-48a	10852-111F6	20.15	7.53	2.21	2.44	0.00
mesothelioma cell line:Mero-82	10853-111F7	24.44	16.03	2.10	1.05	0.26
mesothelioma cell line:Mero-83	10854-111F8	30.47	19.58	2.38	1.19	0.17
mesothelioma cell line:Mero-84	10855-111F9	7.58	2.53	0.51	0.51	0.00
mesothelioma cell line:Mero-95	10856-111G1	28.57	17.60	4.55	1.04	0.21
mesothelioma cell line:NCI-H2052	10847-111F1	22.53	8.28	2.32	0.83	0.17
mesothelioma cell line:NCI-H226	10846-111E9	33.66	17.74	5.25	2.35	0.54
mesothelioma cell line:NCI-H2452	10848-111F2	22.89	9.57	2.05	0.85	0.17
mesothelioma cell line:NCI-H28	10845-111E8	5.34	4.33	0.25	0.00	0.00
mesothelioma cell line:No36	10857-111G2	0.98	0.33	0.00	0.00	0.00
mesothelioma cell line:ONE58	10858-111G3	12.73	10.30	1.35	1.90	0.00
migratory langerhans cells, donor1	11901-125F2	26.10	25.53	2.69	0.96	0.00
migratory langerhans cells, donor2	11902-125F3	21.00	7.82	1.71	1.71	0.00
migratory langerhans cells, donor3	11903-125F4	25.49	13.64	2.87	0.72	0.00
mixed mullerian tumor cell line:HTMMT	10689-109F5	4.24	4.57	0.33	1.96	0.00
mucinous adenocarcinoma cell line:JHOM-1	10648-109A9	70.57	12.72	9.33	6.99	0.85
mucinous cystadenocarcinoma cell line:MCAS	10784-110H1	29.03	3.46	1.38	5.07	4.15
mycosis fungoides, T cell lymphoma cell line:HuT 102 TIB-162	10744-110C6	55.38	2.85	10.28	5.90	1.52
myelodysplastic syndrome cell line:SKM-1	10772-110F7	36.77	2.96	5.73	2.40	0.55
myeloma cell line:PCM6	10474-106I6	8.90	2.37	0.20	0.99	0.79
myxofibrosarcoma cell line:MFH-ino	10600-108E6	11.67	1.01	2.54	1.52	2.54
myxofibrosarcoma cell line:NMFH-1	10684-109E9	63.55	8.04	13.14	11.38	3.92
nasal epithelial cells, donor1, tech_rep1	12226-129F3	19.39	14.71	2.45	0.33	0.11
nasal epithelial cells, donor1, tech_rep2	12226-129F3	23.97	15.22	2.57	0.88	0.15
nasal epithelial cells, donor2	12227-129F4	21.53	10.49	4.42	0.00	0.55
neuroblastoma cell line:CHP-134	10508-107D4	35.20	9.89	3.91	4.83	0.23
neuroblastoma cell line:NB-1	10539-107G8	11.97	3.55	2.81	1.68	0.00
neuroblastoma cell line:NBsusSR	10607-108F4	84.57	3.80	17.93	11.81	1.69
neuroblastoma cell line:NH-12	10555-107I6	42.86	13.42	6.71	9.13	0.56
neuroectodermal tumor cell line:FU-RPNT-1	10637-108I7	11.86	2.14	1.90	1.66	0.00
neuroectodermal tumor cell line:FU-RPNT-2	10663-109C6	35.95	4.43	7.60	3.17	1.11
neuroectodermal tumor cell line:TASK1	10774-110F9	9.86	5.03	0.81	0.81	0.00
neuroepithelioma cell line:SK-N-MC	10728-110A8	41.32	0.64	5.72	1.27	0.00
neurofibroma cell line:Hs 53.T	10729-110A9	17.57	1.86	4.52	3.46	1.06
neutrophil PMN, donor1	12133-128D9	0.00	0.00	0.00	0.00	0.00
neutrophil PMN, donor2	12137-128E4	26.56	0.00	0.00	0.00	0.00
neutrophil PMN, donor3	12141-128E8	0.00	0.00	0.00	0.00	0.00
non T non B acute lymphoblastic leukemia (ALL) cell line:P30/OHK	10430-106D7	38.05	3.21	6.76	6.09	1.01
non-small cell lung cancer cell line:NCI-H1385	10730-110B1	52.03	4.80	19.21	6.40	1.60
normal embryonic palatal mesenchymal cell line:HEPM	10813-111B3	40.40	3.85	7.05	1.60	0.32
normal intestinal epithelial cell line:FHs 74 Int	10812-111B2	24.44	6.31	4.73	4.47	2.89
nucleus accumbens, adult, pool1	10037-101F1	40.68	9.47	2.72	0.47	0.09
occipital cortex - adult, donor10196	10172-103C1	43.27	16.48	0.00	0.00	2.06
occipital cortex, adult, donor10252	10163-103B1	37.30	19.59	1.88	0.81	0.27
occipital cortex, newborn, donor10223	10355-105E4	50.95	11.65	2.55	1.09	0.73
occipital lobe, adult, donor1	10076-102A4	22.30	6.56	2.10	0.79	0.00
occipital lobe, fetal, donor1	10073-102A1	26.18	12.01	2.57	0.86	0.00
occipital pole, adult, pool1	10036-101E9	35.08	9.38	2.37	1.02	0.08
olfactory region, adult	10195-103E6	28.08	7.64	2.67	0.76	0.38
optic nerve, donor1	10277-104E7	10.01	6.00	0.00	0.00	0.00
oral squamous cell carcinoma cell line:Ca9-22	10434-106E2	16.63	1.48	2.73	3.53	0.57
oral squamous cell carcinoma cell line:HO-1-u-1	10550-107I1	53.31	9.75	7.14	6.18	0.14
oral squamous cell carcinoma cell line:HSC-3	10545-107H5	21.84	5.25	3.73	5.93	0.51
oral squamous cell carcinoma cell line:SAS	10544-107H4	171.99	33.27	27.38	9.82	3.23
osteoclastoma cell line:Hs 706.T	10704-109H2	32.34	3.53	6.17	5.29	2.06
osteosarcoma cell line:143B/TK^(-)neo^(R)	10510-107D6	71.94	11.21	25.23	13.08	2.80
osteosarcoma cell line:HS-Os-1	10558-107I9	39.02	2.97	9.54	6.15	1.27
ovary, adult, pool1	10020-101D2	70.23	14.85	7.86	1.14	0.35
pagetoid sarcoma cell line:Hs 925.T	10732-110B3	52.80	11.73	10.08	2.20	1.10
pancreas, adult, donor1	10049-101G4	96.89	18.81	18.81	4.70	0.00
pancreatic carcinoma cell line:NOR-P1	10698-109G5	0.28	0.56	0.00	0.28	0.00
papillary adenocarcinoma cell line:8505C	10437-106E5	21.81	6.81	5.28	7.67	1.36
papillotubular adenocarcinoma cell line:TGBC18TKB	10417-106C3	48.85	8.11	9.44	10.93	1.32
paracentral gyrus, adult, pool1	10035-101E8	42.74	12.26	4.39	1.65	0.09
parietal cortex, adult, donor10258	10373-105G4	15.41	3.67	0.00	0.00	0.00
parietal lobe - adult, donor10196	10171-103B9	47.96	12.23	3.76	0.00	0.00
parietal lobe, adult, donor10252	10157-103A4	50.17	18.81	1.43	1.43	0.00
parietal lobe, adult, pool1	10034-101E7	46.88	11.19	2.56	0.97	0.00
parietal lobe, fetal, donor1	10072-101I9	15.52	7.76	0.00	0.00	0.97
parietal lobe, newborn, donor10223	10356-105E5	49.35	23.18	1.87	2.62	0.75
parotid gland, adult	10199-103F1	23.43	6.78	1.85	0.00	0.00
penis, adult	10200-103F2	105.81	11.82	10.74	3.76	0.54
peripheral neuroectodermal tumor cell line:KU-SN	10697-109G4	27.89	4.09	4.65	7.07	1.86
pharyngeal carcinoma cell line:Detroit 562	10723-110A3	48.81	8.60	8.60	2.19	0.87
pineal gland - adult, donor10196	10179-103C8	11.61	1.29	0.00	0.00	0.00
pineal gland, adult, donor10252	10160-103A7	29.02	8.29	0.00	1.18	0.00
pineal gland, adult, donor10258	10377-105G8	12.54	2.51	0.63	0.00	0.00
pituitary gland - adult, donor10196	10180-103C9	33.39	7.08	2.02	1.01	0.00
pituitary gland, adult, donor10252	10162-103A9	33.88	13.55	2.61	0.00	0.00
pituitary gland, adult, donor10258	10378-105G9	12.77	1.70	0.00	0.00	0.00
placenta, adult, pool1	10021-101D3	41.93	12.04	8.28	0.65	0.11
plasma cell leukemia cell line:ARH-77	10840-111E3	35.76	0.79	4.77	7.02	0.40
pleomorphic hepatocellular carcinoma cell line:SNU-387	10706-109H4	79.53	8.09	14.32	7.47	1.71
pons, adult, pool1	10033-101E6	29.44	9.81	2.58	0.52	0.09
postcentral gyrus, adult, pool1	10032-101E5	39.66	9.76	3.31	0.87	0.09
promyelocytes/myelocytes PMC, donor1	12132-128D8	14.64	6.27	4.18	0.00	0.00
promyelocytes/myelocytes PMC, donor2	12136-128E3	33.05	5.51	5.51	0.00	0.00
promyelocytes/myelocytes PMC, donor3	12140-128E7	0.00	23.47	0.00	0.00	0.00
prostate cancer cell line:DU145	10490-107B4	28.40	3.64	7.57	6.26	1.89
prostate cancer cell line:PC-3	10439-106E7	39.57	8.35	11.80	6.90	3.09
prostate, adult, pool1	10022-101D4	87.43	23.58	7.35	0.54	0.36
putamen, adult, donor10196	10176-103C5	44.62	21.48	2.83	1.18	0.24
putamen, adult, donor10252	10152-102I8	3.92	7.84	0.00	0.00	0.00
putamen, adult, donor10258, tech_rep1	10372-105G3	19.67	2.19	0.00	0.00	0.00
putamen, adult, donor10258, tech_rep2	10372-105G3	12.32	4.11	0.00	0.24	0.00
putamen, newborn, donor10223	10365-105F5	71.22	42.73	3.00	0.75	0.00
rectal cancer cell line:TT1TKB	10469-106I1	73.32	23.86	16.29	6.98	2.62
rectum, fetal, donor1	10067-101I4	31.99	25.04	2.78	0.00	0.00
renal cell carcinoma cell line:OS-RC-2	10411-106B6	43.25	7.84	5.09	5.51	1.27
renal cell carcinoma cell line:TUHR10TKB	10471-106I3	33.14	4.56	3.31	1.66	0.00
retina, adult, pool1	10030-101E3	125.14	18.69	17.00	1.59	0.20
retinoblastoma cell line:Y79	10475-106I7	5.98	1.56	0.78	0.52	0.00
rhabdomyosarcoma cell line:KYM-1	10787-110H4	0.25	0.12	0.00	0.00	0.00
rhabdomyosarcoma cell line:RMS-YM	10477-106I9	9.84	2.25	1.69	2.25	0.84
sacrococcigeal teratoma cell line:HTST	10695-109G2	32.59	1.52	6.82	4.55	4.55
salivary acinar cells, donor1	11771-123I7	5.34	1.94	0.16	0.32	0.00
salivary acinar cells, donor2	11772-123I8	7.71	3.17	0.83	0.28	0.14
salivary acinar cells, donor3	11773-123I9	3.31	3.31	1.99	0.66	0.66
salivary gland, adult, pool1	10093-102C3	66.35	17.73	5.72	1.14	0.00
schwannoma cell line:HS-PSS, tech_rep1	10442-106F1	43.67	17.71	4.22	3.63	0.76
schwannoma cell line:HS-PSS, tech_rep2	10442-106F1	41.38	19.04	4.58	2.82	0.82
seminal vesicle, adult	10201-103F3	94.17	18.52	15.34	2.65	0.53
serous adenocarcinoma cell line:JHOS-2	10639-108I9	74.09	16.76	11.17	6.07	0.97
serous adenocarcinoma cell line:SK-OV-3-R after co-culture with SOC-57-02-G, biol_rep1	11843-124H7	49.57	11.83	15.85	2.01	0.00
serous adenocarcinoma cell line:SK-OV-3-R, biol_rep1	11841-124H5	44.16	23.08	17.06	8.03	3.01
serous cystadenocarcinoma cell line:HTOA	10693-109F9	119.81	40.70	20.55	7.92	2.55
signet ring carcinoma cell line:Kato III	10436-106E4	29.40	7.07	3.76	6.63	0.88
signet ring carcinoma cell line:NUGC-4	10483-107A6	42.45	7.48	9.16	9.42	1.42
skeletal muscle - soleus muscle, donor1	10282-104F3	21.28	0.00	1.42	2.13	0.71
skeletal muscle, adult, pool1	10023-101D5	78.20	8.16	7.92	0.60	1.20
skeletal muscle, fetal, donor1	10066-101I3	40.20	7.04	6.03	1.01	0.00
skin, adult, donor1	10074-102A2	33.93	6.79	0.00	0.00	0.00
skin, fetal, donor1	10065-101I2	100.37	19.57	15.15	5.05	0.63
small cell cervical cancer cell line:HCSC-1	10800-110I8	64.04	3.00	20.68	5.00	2.00
small cell gastrointestinal carcinoma cell line:ECC10	10610-108F7	53.27	10.40	7.56	12.29	0.32
small cell lung carcinoma cell line:DMS 144	10841-111E4	148.99	14.26	32.57	5.78	1.73
small cell lung carcinoma cell line:LK-2	10541-107H1	23.74	6.76	5.60	7.58	0.82
small cell lung carcinoma cell line:NCI-H82	10842-111E5	34.58	6.59	7.88	9.81	0.64
small cell lung carcinoma cell line:WA-hT	10562-108A4	63.85	13.73	24.84	7.41	0.44
small intestine, adult, pool1	10024-101D6	63.42	37.27	10.63	1.55	0.12
small intestine, fetal, donor1	10064-101I1	52.33	47.91	9.58	1.72	0.25
small-cell gastrointestinal carcinoma cell line:ECC4	10609-108F6	14.36	2.56	1.03	3.08	1.03
smooth muscle, adult, pool1	10048-101G3	89.94	9.05	11.37	0.26	0.00
somatostatinoma cell line:QGP-1	10781-110G7	16.35	1.34	3.48	3.48	0.80
spinal cord - adult, donor10196	10181-103D1	41.29	14.91	3.21	0.92	0.00
spinal cord, adult, donor10252	10159-103A6	34.30	16.95	0.79	0.00	0.00
spinal cord, adult, donor10258	10369-105F9	80.94	11.07	5.53	2.08	0.00
spinal cord, fetal, donor1	10056-101H2	126.24	32.93	23.78	1.22	0.00
spinal cord, newborn, donor10223	10359-105E8	31.69	21.12	0.46	0.46	0.00
spindle cell sarcoma cell line:Hs 132.T	10737-110B8	18.07	1.94	3.29	1.79	0.15
spleen, adult, pool1	10025-101D7	15.64	4.85	1.21	0.11	0.00
spleen, fetal, pool1	10044-101F8	78.90	11.92	8.74	1.19	0.32
splenic lymphoma with villous lymphocytes cell line:SLVL	10424-106D1	13.87	0.72	1.97	1.97	0.10
squamous cell carcinoma cell line:EC-GI-10	10463-106H4	21.84	4.18	3.80	2.09	0.19
squamous cell carcinoma cell line:JHUS-nk1	10646-109A7	14.68	2.45	2.45	1.40	0.35
squamous cell carcinoma cell line:T3M-5	10616-108G4	65.29	12.12	10.56	10.56	2.74
squamous cell lung carcinoma cell line:EBC-1	10486-107A9	72.26	31.85	5.29	4.16	0.68
squamous cell lung carcinoma cell line:LC-1F	10457-106G7	21.18	3.39	3.39	8.47	1.27
squamous cell lung carcinoma cell line:RERF-LC-AI	10501-107C6	8.46	2.54	2.96	2.96	1.27
stomach, fetal, donor1	10062-101H8	84.37	13.88	19.22	1.07	2.14
submaxillary gland, adult	10202-103F4	33.04	14.24	1.14	0.00	0.00
substantia nigra - adult, donor10196	10178-103C7	162.82	54.27	0.00	0.00	0.00
substantia nigra, adult, donor10252	10158-103A5	42.58	14.95	2.70	0.21	0.21
substantia nigra, adult, donor10258	10371-105G2	30.00	5.69	1.03	0.52	0.00
substantia nigra, newborn, donor10223	10358-105E7	24.73	19.78	2.12	0.71	1.41
synovial sarcoma cell line:HS-SY-II	10441-106E9	2.52	0.69	0.92	0.46	0.23
temporal lobe, adult, pool1	10031-101E4	48.49	11.87	3.39	1.78	0.25
temporal lobe, fetal, donor1, tech_rep1	10063-101H9	32.76	18.52	6.41	0.71	0.71
temporal lobe, fetal, donor1, tech_rep2	10063-101H9	28.57	14.07	2.64	0.88	0.00
tenocyte, donor1	11763-123H8	28.63	17.46	5.59	0.70	0.00
tenocyte, donor2	11765-123I1	31.66	24.03	4.58	3.05	0.00
tenocyte, donor3	11768-123I4	33.36	21.87	4.82	1.11	0.37
teratocarcinoma cell line:NCC-IT-A3	10790-110H7	8.50	5.61	0.68	1.70	0.00
teratocarcinoma cell line:NCR-G1	10798-110I6	41.47	3.85	8.02	1.39	0.00
teratocarcinoma cell line:PA-1	10807-111A6	38.90	7.28	6.20	5.73	0.31
testicular germ cell embryonal carcinoma cell line:ITO-II	10786-110H3	15.61	4.70	0.89	0.25	0.13
testicular germ cell embryonal carcinoma cell line:NEC14	10591-108D6	9.08	4.16	0.76	0.38	0.00
testicular germ cell embryonal carcinoma cell line:NEC15	10593-108D8	22.79	14.61	2.51	0.55	0.44
testicular germ cell embryonal carcinoma cell line:NEC8	10590-108D5	10.42	2.28	0.33	1.30	0.00
testis, adult, pool1	10026-101D8	69.04	17.82	6.12	1.50	0.21
testis, adult, pool2	10096-102C6	35.64	9.47	8.12	0.45	0.00
thalamus - adult, donor10196	10168-103B6	73.97	18.77	2.21	0.00	0.00
thalamus, adult, donor10252	10154-103A1	54.23	17.97	3.91	0.16	0.16
thalamus, adult, donor10258, tech_rep1	10370-105G1	132.41	9.24	4.62	0.00	0.00
thalamus, adult, donor10258, tech_rep2	10370-105G1	26.35	6.75	2.14	0.33	0.00
thalamus, newborn, donor10223	10366-105F6	42.00	20.14	0.58	0.00	0.00
throat, adult	10209-103G2	78.40	19.72	7.74	2.00	0.75
throat, fetal, donor1	10061-101H7	96.90	25.90	15.54	1.22	0.30
thymic carcinoma cell line:Ty-82	10803-111A2	1.19	0.99	0.20	0.20	0.00
thymus, adult, pool1	10027-101D9	19.49	8.45	2.29	0.60	0.20
thymus, fetal, pool1	10043-101F7	121.57	21.61	8.83	2.08	1.14
thyroid carcinoma cell line:KHM-5M	10776-110G2	42.68	12.90	6.38	9.31	1.86
thyroid carcinoma cell line:TCO-1	10783-110G9	60.35	11.45	20.81	13.55	3.77
thyroid, adult, pool1	10028-101E1	57.85	29.77	5.69	0.75	0.19
thyroid, fetal, donor1	10060-101H6	76.20	21.09	15.29	1.58	0.00
tongue epidermis (fungiform papillae), donor1	10288-104F9	33.88	9.24	3.08	0.00	0.00
tongue, adult	10203-103F5	74.19	11.63	9.54	2.09	0.00
tongue, fetal, donor1	10059-101H5	100.89	17.73	9.85	0.79	0.39
tonsil, adult, pool1	10047-101G2	62.41	19.93	5.51	1.40	0.20
trachea, adult, pool1	10029-101E2	73.78	23.64	7.44	0.74	0.25
trachea, fetal, donor1	10058-101H4	70.01	32.31	6.54	1.15	0.38
transitional cell carcinoma cell line:Hs 769.T	10707-109H5	20.19	4.61	4.61	1.06	0.35
transitional-cell carcinoma cell line:5637	10418-106C4	30.29	9.73	3.65	6.79	2.13
transitional-cell carcinoma cell line:JMSU1	10492-107B6	189.43	18.96	38.86	9.24	2.82
tridermal teratoma cell line:HGRT	10694-109G1	15.22	3.81	0.00	5.71	1.90
tubular adenocarcinoma cell line:SUIT-2	10797-110I5	45.54	5.76	10.24	9.90	3.13
umbilical cord, fetal, donor1	10057-101H3	87.63	8.35	31.30	0.00	2.09
uterus, adult, pool1	10100-102D1	126.61	24.23	10.58	1.71	0.17
uterus, fetal, donor1	10055-101H1	45.05	25.60	3.07	0.00	1.02
vagina, adult	10204-103F6	33.60	19.39	1.29	0.00	0.00
vein, adult	10191-103E2	45.15	11.40	3.73	1.10	0.22
xeroderma pigentosum b cell line:XPL 17	10563-108A5	6.68	0.80	0.27	0.80	0.00